CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: 4H-pyran
Accession: CHEBI:35593
browse the term
Definition: A pyran that has formula C5H6O.
Synonyms: related_synonym: Formula=C5H6O; InChI=1S/C5H6O/c1-2-4-6-5-3-1/h2-5H,1H2; InChIKey=MRUWJENAYHTDQG-UHFFFAOYSA-N; SMILES=C1C=COC=C1
xref: Beilstein:1421312; CAS:289-65-6
cyclic_relationship: is_tautomer_of CHEBI:35592
G
ABCA11P
ATP binding cassette subfamily A member 11, pseudogene
decreases expression
EXP
kojic acid results in decreased expression of ABCA11P mRNA
CTD
PMID:16595896
NCBI chr 4:425,435...474,209
Ensembl chr 4:425,773...427,882 Ensembl chr 4:425,773...427,882
G
ABCA13
ATP binding cassette subfamily A member 13
decreases expression
EXP
kojic acid results in decreased expression of ABCA13 mRNA
CTD
PMID:16595896
NCBI chr 7:48,171,458...48,647,497
Ensembl chr 7:48,171,458...48,647,497
G
ABCC13
ATP binding cassette subfamily C member 13 (pseudogene)
decreases expression
EXP
kojic acid results in decreased expression of ABCC13 mRNA
CTD
PMID:16595896
NCBI chr21:14,273,799...14,301,386
Ensembl chr21:14,236,206...14,338,017 Ensembl chr21:14,236,206...14,338,017
G
ABCC2
ATP binding cassette subfamily C member 2
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in increased expression of ABCC2 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in decreased expression of ABCC2 mRNA
CTD
PMID:18544905
NCBI chr10:99,782,640...99,852,594
Ensembl chr10:99,782,640...99,852,594
G
ABCC6
ATP binding cassette subfamily C member 6
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid] results in increased expression of ABCC6 mRNA [Diethylnitrosamine co-treated with kojic acid] results in decreased expression of ABCC6 mRNA
CTD
PMID:17917374 PMID:18544905
NCBI chr16:16,149,565...16,223,494
Ensembl chr16:16,149,565...16,223,522
G
ABCC9
ATP binding cassette subfamily C member 9
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid] results in increased expression of ABCC9 mRNA
CTD
PMID:17917374
NCBI chr12:21,797,389...21,941,426
Ensembl chr12:21,797,389...21,942,543
G
ABCD1
ATP binding cassette subfamily D member 1
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid] results in increased expression of ABCD1 mRNA
CTD
PMID:17917374
NCBI chr X:153,724,856...153,744,755
Ensembl chr X:153,724,856...153,744,755
G
ABCF2
ATP binding cassette subfamily F member 2
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid] results in increased expression of ABCF2 mRNA
CTD
PMID:17917374
NCBI chr 7:151,211,484...151,227,205
Ensembl chr 7:151,211,484...151,227,205
G
ABHD1
abhydrolase domain containing 1
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid] results in decreased expression of ABHD1 mRNA
CTD
PMID:17917374
NCBI chr 2:27,123,815...27,130,812
Ensembl chr 2:27,123,789...27,130,812
G
ACER3
alkaline ceramidase 3
increases expression
EXP
kojic acid results in increased expression of ACER3 mRNA
CTD
PMID:16595896
NCBI chr11:76,860,918...77,026,797
Ensembl chr11:76,860,859...77,026,797
G
ACMSD
aminocarboxymuconate semialdehyde decarboxylase
decreases expression
EXP
kojic acid results in decreased expression of ACMSD mRNA
CTD
PMID:16595896
NCBI chr 2:134,838,616...134,902,034
Ensembl chr 2:134,838,616...134,902,034
G
ACVRL1
activin A receptor like type 1
decreases expression
EXP
kojic acid results in decreased expression of ACVRL1 mRNA
CTD
PMID:16595896
NCBI chr12:51,906,944...51,923,361
Ensembl chr12:51,906,908...51,923,361
G
ADAM20
ADAM metallopeptidase domain 20
decreases expression
EXP
kojic acid results in decreased expression of ADAM20 mRNA
CTD
PMID:16595896
NCBI chr14:70,522,358...70,579,452
Ensembl chr14:70,522,358...70,535,015
G
ADRB3
adrenoceptor beta 3
decreases expression
EXP
kojic acid results in decreased expression of ADRB3 mRNA
CTD
PMID:16595896
NCBI chr 8:37,962,990...37,966,599
Ensembl chr 8:37,962,990...37,966,599
G
AGAP3
ArfGAP with GTPase domain, ankyrin repeat and PH domain 3
increases expression
EXP
kojic acid results in increased expression of AGAP3 mRNA
CTD
PMID:16595896
NCBI chr 7:151,085,867...151,144,434
Ensembl chr 7:151,085,831...151,144,436
G
AGBL4
AGBL carboxypeptidase 4
decreases expression
EXP
kojic acid results in decreased expression of AGBL4 mRNA
CTD
PMID:16595896
NCBI chr 1:48,522,511...50,023,954
Ensembl chr 1:48,532,854...50,023,954
G
AHNAK
AHNAK nucleoprotein
decreases expression
EXP
kojic acid results in decreased expression of AHNAK mRNA
CTD
PMID:16595896
NCBI chr11:62,433,544...62,546,806
Ensembl chr11:62,433,542...62,556,235
G
AKT1
AKT serine/threonine kinase 1
decreases expression
EXP
kojic acid results in decreased expression of AKT1 mRNA
CTD
PMID:16595896
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,751
G
ALPI
alkaline phosphatase, intestinal
decreases expression
EXP
kojic acid results in decreased expression of ALPI mRNA
CTD
PMID:16595896
NCBI chr 2:232,456,153...232,460,753
Ensembl chr 2:232,456,125...232,460,753
G
AMTN
amelotin
decreases expression
EXP
kojic acid results in decreased expression of AMTN mRNA
CTD
PMID:16595896
NCBI chr 4:70,518,569...70,532,743
Ensembl chr 4:70,518,569...70,532,743
G
ANXA1
annexin A1
decreases expression
EXP
kojic acid results in decreased expression of ANXA1 mRNA
CTD
PMID:16595896
NCBI chr 9:73,151,865...73,170,393
Ensembl chr 9:73,151,865...73,170,393
G
ANXA5
annexin A5
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of ANXA5 mRNA
CTD
PMID:17917374
NCBI chr 4:121,667,946...121,696,980
Ensembl chr 4:121,667,946...121,696,995
G
AP1S1
adaptor related protein complex 1 subunit sigma 1
decreases expression
EXP
kojic acid results in decreased expression of AP1S1 mRNA
CTD
PMID:16595896
NCBI chr 7:101,154,476...101,161,276
Ensembl chr 7:101,154,456...101,161,596
G
APOBEC1
apolipoprotein B mRNA editing enzyme catalytic subunit 1
decreases expression
EXP
kojic acid results in decreased expression of APOBEC1 mRNA
CTD
PMID:16595896
NCBI chr12:7,649,400...7,670,599
Ensembl chr12:7,649,400...7,665,908
G
APP
amyloid beta precursor protein
increases expression
EXP
kojic acid results in increased expression of APP mRNA
CTD
PMID:16595896
NCBI chr21:25,880,550...26,171,128
Ensembl chr21:25,880,535...26,171,128
G
APTX
aprataxin
decreases expression
EXP
kojic acid results in decreased expression of APTX mRNA
CTD
PMID:16595896
NCBI chr 9:32,972,616...33,025,120
Ensembl chr 9:32,886,601...33,025,130
G
AQP1
aquaporin 1 (Colton blood group)
increases expression
EXP
kojic acid results in increased expression of AQP1 mRNA
CTD
PMID:16595896
NCBI chr 7:30,911,853...30,925,516
Ensembl chr 7:30,911,853...30,925,517
G
ARFIP2
ADP ribosylation factor interacting protein 2
decreases expression
EXP
kojic acid results in decreased expression of ARFIP2 mRNA
CTD
PMID:16595896
NCBI chr11:6,476,519...6,481,331
Ensembl chr11:6,474,683...6,481,479
G
ARHGEF16
Rho guanine nucleotide exchange factor 16
decreases expression
EXP
kojic acid results in decreased expression of ARHGEF16 mRNA
CTD
PMID:16595896
NCBI chr 1:3,454,665...3,481,113
Ensembl chr 1:3,454,665...3,481,113
G
ARL6IP5
ADP ribosylation factor like GTPase 6 interacting protein 5
increases expression
EXP
kojic acid results in increased expression of ARL6IP5 mRNA
CTD
PMID:16595896
NCBI chr 3:69,084,937...69,106,092
Ensembl chr 3:69,084,937...69,106,092
G
ASNSD1
asparagine synthetase domain containing 1
decreases expression
EXP
kojic acid results in decreased expression of ASNSD1 mRNA
CTD
PMID:16595896
NCBI chr 2:189,661,459...189,670,831
Ensembl chr 2:189,661,385...189,670,831
G
ATF6B
activating transcription factor 6 beta
decreases expression
EXP
kojic acid results in decreased expression of ATF6B mRNA
CTD
PMID:16595896
NCBI chr 6:32,115,264...32,128,246
Ensembl chr 6:32,115,264...32,128,253
G
ATM
ATM serine/threonine kinase
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of ATM mRNA
CTD
PMID:17917374
NCBI chr11:108,223,067...108,369,102
Ensembl chr11:108,222,823...108,369,102
G
B4GALNT4
beta-1,4-N-acetyl-galactosaminyltransferase 4
decreases expression
EXP
kojic acid results in decreased expression of B4GALNT4 mRNA
CTD
PMID:16595896
NCBI chr11:369,499...382,117
Ensembl chr11:369,499...382,117
G
BAG5
BAG cochaperone 5
decreases expression
EXP
kojic acid results in decreased expression of BAG5 mRNA
CTD
PMID:16595896
NCBI chr14:103,556,551...103,562,657
Ensembl chr14:103,556,545...103,562,657
G
BCL2A1
BCL2 related protein A1
increases expression
EXP
kojic acid results in increased expression of BCL2A1 mRNA
CTD
PMID:16595896
NCBI chr15:79,960,892...79,971,196
Ensembl chr15:79,960,892...79,971,196
G
BCL2L2
BCL2 like 2
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of BCL2L2 mRNA
CTD
PMID:17917374
NCBI chr14:23,306,833...23,311,751
Ensembl chr14:23,298,790...23,311,751
G
BIRC2
baculoviral IAP repeat containing 2
decreases expression
EXP
kojic acid results in decreased expression of BIRC2 mRNA
CTD
PMID:16595896
NCBI chr11:102,347,214...102,378,670
Ensembl chr11:102,347,211...102,378,670
G
BMP5
bone morphogenetic protein 5
decreases expression
EXP
kojic acid results in decreased expression of BMP5 mRNA
CTD
PMID:16595896
NCBI chr 6:55,753,653...55,875,590
Ensembl chr 6:55,753,653...55,875,590
G
BRSK1
BR serine/threonine kinase 1
decreases expression
EXP
kojic acid results in decreased expression of BRSK1 mRNA
CTD
PMID:16595896
NCBI chr19:55,283,997...55,312,562
Ensembl chr19:55,282,072...55,312,562
G
BST2
bone marrow stromal cell antigen 2
decreases expression
EXP
kojic acid results in decreased expression of BST2 mRNA
CTD
PMID:16595896
NCBI chr19:17,402,939...17,405,630
Ensembl chr19:17,402,939...17,405,630
G
C1orf131
chromosome 1 open reading frame 131
decreases expression
EXP
kojic acid results in decreased expression of C1ORF131 mRNA
CTD
PMID:16595896
NCBI chr 1:231,223,765...231,241,175
Ensembl chr 1:231,223,763...231,241,187
G
C1orf54
chromosome 1 open reading frame 54
increases expression
EXP
kojic acid results in increased expression of C1ORF54 mRNA
CTD
PMID:16595896
NCBI chr 1:150,268,731...150,280,924
Ensembl chr 1:150,268,200...150,280,916
G
C1orf87
chromosome 1 open reading frame 87
decreases expression
EXP
kojic acid results in decreased expression of C1ORF87 mRNA
CTD
PMID:16595896
NCBI chr 1:59,990,394...60,073,770
Ensembl chr 1:59,987,269...60,073,770
G
CA13
carbonic anhydrase 13
increases expression
ISO
kojic acid results in increased expression of CAR13 mRNA
CTD
PMID:19000923
NCBI chr 8:85,245,458...85,284,073
Ensembl chr 8:85,220,587...85,284,073
G
CA14
carbonic anhydrase 14
increases expression
EXP
kojic acid results in increased expression of CA14 mRNA
CTD
PMID:16595896
NCBI chr 1:150,257,774...150,265,078
Ensembl chr 1:150,257,251...150,265,078
G
CAB39L
calcium binding protein 39 like
increases expression
EXP
kojic acid results in increased expression of CAB39L mRNA
CTD
PMID:16595896
NCBI chr13:49,308,650...49,444,064
Ensembl chr13:49,308,650...49,444,064
G
CALR
calreticulin
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CALR mRNA
CTD
PMID:18544905
NCBI chr19:12,938,609...12,944,489
Ensembl chr19:12,938,578...12,944,489
G
CASP4
caspase 4
multiple interactions
ISO
[kojic acid co-treated with Diethylnitrosamine] results in increased expression of CASP4 mRNA; Ascorbic Acid inhibits the reaction [[kojic acid co-treated with Diethylnitrosamine] results in increased expression of CASP4 mRNA]
CTD
PMID:18544905
NCBI chr11:104,942,866...104,968,574
Ensembl chr11:104,942,866...104,969,366
G
CASP8
caspase 8
multiple interactions
ISO
[Ascorbic Acid co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CASP8 mRNA
CTD
PMID:18544905
NCBI chr 2:201,233,463...201,287,711
Ensembl chr 2:201,233,443...201,361,836
G
CAT
catalase
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CAT mRNA
CTD
PMID:18544905
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
G
CCAR1
cell division cycle and apoptosis regulator 1
increases expression
EXP
kojic acid results in increased expression of CCAR1 mRNA
CTD
PMID:16595896
NCBI chr10:68,721,239...68,792,377
Ensembl chr10:68,721,012...68,792,377
G
CCDC144A
coiled-coil domain containing 144A
decreases expression
EXP
kojic acid results in decreased expression of CCDC144A mRNA
CTD
PMID:16595896
NCBI chr17:16,666,717...16,777,881
Ensembl chr17:16,689,537...16,777,881
G
CCDC50
coiled-coil domain containing 50
increases expression
EXP
kojic acid results in increased expression of CCDC50 mRNA
CTD
PMID:16595896
NCBI chr 3:191,329,394...191,398,659
Ensembl chr 3:191,329,085...191,398,659
G
CCL21
C-C motif chemokine ligand 21
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of CCL21A mRNA
CTD
PMID:17917374
NCBI chr 9:34,709,005...34,710,136
Ensembl chr 9:34,709,005...34,710,136
G
CCL3
C-C motif chemokine ligand 3
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of CCL3 mRNA
CTD
PMID:17917374
NCBI chr17:36,088,256...36,090,143
Ensembl chr17:36,088,256...36,090,169
G
CCNB1
cyclin B1
increases expression
ISO
kojic acid results in increased expression of CCNB1 mRNA
CTD
PMID:19000923
NCBI chr 5:69,167,150...69,178,245
Ensembl chr 5:69,167,135...69,178,245
G
CCNC
cyclin C
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of CCNC mRNA
CTD
PMID:17917374
NCBI chr 6:99,542,387...99,568,814
Ensembl chr 6:99,542,387...99,568,825
G
CCND1
cyclin D1
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid] results in decreased expression of CCND1 mRNA [Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of CCND1 mRNA
CTD
PMID:17917374 PMID:18544905
NCBI chr11:69,641,156...69,654,474
Ensembl chr11:69,641,156...69,654,474
G
CCNG1
cyclin G1
multiple interactions
ISO
[Ascorbic Acid co-treated with kojic acid co-treated with Diethylnitrosamine] results in increased expression of CCNG1 mRNA [Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of CCNG1 mRNA
CTD
PMID:17917374 PMID:18544905
NCBI chr 5:163,437,571...163,457,640
Ensembl chr 5:163,437,569...163,446,151
G
CCPG1
cell cycle progression 1
decreases expression
EXP
kojic acid results in decreased expression of CCPG1 mRNA
CTD
PMID:16595896
NCBI chr15:55,355,239...55,408,359
Ensembl chr15:55,340,032...55,408,510
G
CCR4
C-C motif chemokine receptor 4
decreases expression
EXP
kojic acid results in decreased expression of CCR4 mRNA
CTD
PMID:16595896
NCBI chr 3:32,951,644...32,956,349
Ensembl chr 3:32,951,644...32,956,349
G
CD22
CD22 molecule
decreases expression
EXP
kojic acid results in decreased expression of CD22 mRNA
CTD
PMID:16595896
NCBI chr19:35,329,187...35,347,361
Ensembl chr19:35,319,261...35,347,361
G
CD274
CD274 molecule
increases expression
EXP
kojic acid results in increased expression of CD274 mRNA
CTD
PMID:16595896
NCBI chr 9:5,450,542...5,470,554
Ensembl chr 9:5,450,503...5,470,566
G
CD3G
CD3 gamma subunit of T-cell receptor complex
decreases expression
EXP
kojic acid results in decreased expression of CD3G mRNA
CTD
PMID:16595896
NCBI chr11:118,344,344...118,355,161
Ensembl chr11:118,344,344...118,355,161
G
CDIN1
CDAN1 interacting nuclease 1
increases expression
EXP
kojic acid results in increased expression of CDIN1 mRNA
CTD
PMID:16595896
NCBI chr15:36,579,626...36,810,244
Ensembl chr15:36,579,626...36,810,248
G
CDK10
cyclin dependent kinase 10
decreases expression
EXP
kojic acid results in decreased expression of CDK10 mRNA
CTD
PMID:16595896
NCBI chr16:89,686,689...89,696,354
Ensembl chr16:89,680,737...89,696,354
G
CDKN1A
cyclin dependent kinase inhibitor 1A
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of CDKN1A mRNA [Diethylnitrosamine co-treated with kojic acid] results in increased expression of CDKN1A mRNA
CTD
PMID:17917374 PMID:18544905
NCBI chr 6:36,676,463...36,687,332
Ensembl chr 6:36,676,460...36,687,337
G
CDKN1B
cyclin dependent kinase inhibitor 1B
multiple interactions
ISO
[Ascorbic Acid co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CDKN1B mRNA; [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CDKN1B mRNA
CTD
PMID:18544905
NCBI chr12:12,717,368...12,722,369
Ensembl chr12:12,685,498...12,722,369
G
CEACAM1
CEA cell adhesion molecule 1
decreases expression
EXP
kojic acid results in decreased expression of CEACAM1 mRNA
CTD
PMID:16595896
NCBI chr19:42,507,306...42,528,481
Ensembl chr19:42,507,304...42,561,234
G
CEBPD
CCAAT enhancer binding protein delta
increases expression
EXP
kojic acid results in increased expression of CEBPD mRNA
CTD
PMID:16595896
NCBI chr 8:47,736,913...47,738,164
Ensembl chr 8:47,736,913...47,738,164
G
CENPQ
centromere protein Q
decreases expression
EXP
kojic acid results in decreased expression of CENPQ mRNA
CTD
PMID:16595896
NCBI chr 6:49,463,370...49,493,107
Ensembl chr 6:49,463,370...49,493,107
G
CEP192
centrosomal protein 192
increases expression
EXP
kojic acid results in increased expression of CEP192 mRNA
CTD
PMID:16595896
NCBI chr18:12,991,362...13,125,036
Ensembl chr18:12,991,362...13,125,052
G
CEP72
centrosomal protein 72
increases expression
EXP
kojic acid results in increased expression of CEP72 mRNA
CTD
PMID:16595896
NCBI chr 5:612,340...676,616
Ensembl chr 5:612,340...667,168
G
CES1
carboxylesterase 1
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid] results in increased expression of CES1 mRNA
CTD
PMID:18544905
NCBI chr16:55,802,851...55,833,096
Ensembl chr16:55,802,851...55,833,337
G
CHEK2
checkpoint kinase 2
multiple interactions
ISO
[kojic acid co-treated with Diethylnitrosamine] results in increased expression of CHEK2 mRNA; Ascorbic Acid inhibits the reaction [[kojic acid co-treated with Diethylnitrosamine] results in increased expression of CHEK2 mRNA]
CTD
PMID:18544905
NCBI chr22:28,687,743...28,741,834
Ensembl chr22:28,687,743...28,742,422
G
CHST4
carbohydrate sulfotransferase 4
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid] results in decreased expression of CHST4 mRNA
CTD
PMID:17917374
NCBI chr16:71,526,120...71,538,748
Ensembl chr16:71,525,233...71,538,748
G
CIBAR1
CBY1 interacting BAR domain containing 1
increases expression
EXP
kojic acid results in increased expression of CIBAR1 mRNA
CTD
PMID:16595896
NCBI chr 8:93,700,550...93,731,527
Ensembl chr 8:93,698,561...93,731,527
G
CLDN3
claudin 3
decreases expression
EXP
kojic acid results in decreased expression of CLDN3 mRNA
CTD
PMID:16595896
NCBI chr 7:73,768,997...73,770,270
Ensembl chr 7:73,768,997...73,770,270
G
CLDND2
claudin domain containing 2
decreases expression
EXP
kojic acid results in decreased expression of CLDND2 mRNA
CTD
PMID:16595896
NCBI chr19:51,366,739...51,369,003
Ensembl chr19:51,367,098...51,369,003
G
CLEC4C
C-type lectin domain family 4 member C
decreases expression
EXP
kojic acid results in decreased expression of CLEC4C mRNA
CTD
PMID:16595896
NCBI chr12:7,729,383...7,749,541
Ensembl chr12:7,729,383...7,751,605
G
CLMP
CXADR like membrane protein
decreases expression
EXP
kojic acid results in decreased expression of CLMP mRNA
CTD
PMID:16595896
NCBI chr11:123,069,872...123,195,248
Ensembl chr11:123,069,872...123,195,248
G
CLU
clusterin
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CLU mRNA
CTD
PMID:18544905
NCBI chr 8:27,596,917...27,614,700
Ensembl chr 8:27,596,917...27,614,700
G
CNIH1
cornichon family member 1
increases expression
EXP
kojic acid results in increased expression of CNIH1 mRNA
CTD
PMID:16595896
NCBI chr14:54,423,561...54,441,374
Ensembl chr14:54,423,561...54,441,391
G
CNKSR2
connector enhancer of kinase suppressor of Ras 2
decreases expression
EXP
kojic acid results in decreased expression of CNKSR2 mRNA
CTD
PMID:16595896
NCBI chr X:21,374,418...21,654,689
Ensembl chr X:21,372,801...21,654,695
G
COL17A1
collagen type XVII alpha 1 chain
decreases expression
EXP
kojic acid results in decreased expression of COL17A1 mRNA
CTD
PMID:16595896
NCBI chr10:104,031,286...104,085,880
Ensembl chr10:104,031,286...104,085,880
G
COL24A1
collagen type XXIV alpha 1 chain
decreases expression
EXP
kojic acid results in decreased expression of COL24A1 mRNA
CTD
PMID:16595896
NCBI chr 1:85,729,233...86,156,984
Ensembl chr 1:85,729,233...86,156,943
G
COLQ
collagen like tail subunit of asymmetric acetylcholinesterase
increases expression
EXP
kojic acid results in increased expression of COLQ mRNA
CTD
PMID:16595896
NCBI chr 3:15,450,133...15,521,706
Ensembl chr 3:15,450,133...15,521,751
G
COMT
catechol-O-methyltransferase
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of COMT mRNA
CTD
PMID:18544905
NCBI chr22:19,941,772...19,969,975
Ensembl chr22:19,941,371...19,969,975
G
COPS2
COP9 signalosome subunit 2
decreases expression
EXP
kojic acid results in decreased expression of COPS2 mRNA
CTD
PMID:16595896
NCBI chr15:49,122,727...49,155,599
Ensembl chr15:49,106,068...49,155,661
G
COQ10A
coenzyme Q10A
increases expression
EXP
kojic acid results in increased expression of COQ10A mRNA
CTD
PMID:16595896
NCBI chr12:56,266,942...56,270,966
Ensembl chr12:56,266,890...56,270,966
G
COQ8A
coenzyme Q8A
increases expression
EXP
kojic acid results in increased expression of COQ8A mRNA
CTD
PMID:16595896
NCBI chr 1:226,940,294...226,987,544
Ensembl chr 1:226,940,286...226,987,544
G
CPB1
carboxypeptidase B1
decreases expression
EXP
kojic acid results in decreased expression of CPB1 mRNA
CTD
PMID:16595896
NCBI chr 3:148,827,811...148,860,187
Ensembl chr 3:148,791,102...148,860,187
G
CPE
carboxypeptidase E
increases expression
EXP
kojic acid results in increased expression of CPE mRNA
CTD
PMID:16595896
NCBI chr 4:165,379,008...165,498,547
Ensembl chr 4:165,361,194...165,498,547
G
CPNE5
copine 5
increases expression
EXP
kojic acid results in increased expression of CPNE5 mRNA
CTD
PMID:16595896
NCBI chr 6:36,740,775...36,839,998
Ensembl chr 6:36,740,775...36,839,444
G
CREB1
cAMP responsive element binding protein 1
decreases phosphorylation
ISO
kojic acid results in decreased phosphorylation of CREB1 protein
CTD
PMID:27586645
NCBI chr 2:207,529,962...207,605,988
Ensembl chr 2:207,529,737...207,605,988
G
CSE1L
chromosome segregation 1 like
decreases expression
EXP
kojic acid results in decreased expression of CSE1L mRNA
CTD
PMID:16595896
NCBI chr20:49,046,312...49,096,949
Ensembl chr20:49,046,246...49,096,960
G
CTNNAL1
catenin alpha like 1
decreases expression
EXP
kojic acid results in decreased expression of CTNNAL1 mRNA
CTD
PMID:16595896
NCBI chr 9:108,942,577...109,013,499
Ensembl chr 9:108,942,569...109,013,522
G
CTSZ
cathepsin Z
increases expression
EXP
kojic acid results in increased expression of CTSZ mRNA
CTD
PMID:16595896
NCBI chr20:58,995,185...59,007,254
Ensembl chr20:58,985,686...59,008,238
G
CYB5R3
cytochrome b5 reductase 3
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CYB5R3 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of CYB5R3 mRNA
CTD
PMID:18544905
NCBI chr22:42,617,840...42,649,392
Ensembl chr22:42,615,730...42,720,870
G
CYP26B1
cytochrome P450 family 26 subfamily B member 1
increases expression
EXP
kojic acid results in increased expression of CYP26B1 mRNA
CTD
PMID:16595896
NCBI chr 2:72,129,238...72,147,862
Ensembl chr 2:72,129,238...72,147,862
G
CYP2A6
cytochrome P450 family 2 subfamily A member 6
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of CYP2A5 mRNA
CTD
PMID:17917374
NCBI chr19:40,843,541...40,850,447
Ensembl chr19:40,843,541...40,850,447
G
CYP2B6
cytochrome P450 family 2 subfamily B member 6
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of CYP2B10 mRNA
CTD
PMID:17917374
NCBI chr19:40,991,282...41,018,398
Ensembl chr19:40,991,282...41,018,398
G
CYP2C18
cytochrome P450 family 2 subfamily C member 18
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CYP2C mRNA
CTD
PMID:18544905
NCBI chr10:94,683,729...94,736,190
Ensembl chr10:94,683,729...94,736,190
G
CYP2D6
cytochrome P450 family 2 subfamily D member 6
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CYP2D22 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of CYP2D22 mRNA
CTD
PMID:18544905
NCBI chr22:42,126,499...42,130,810
Ensembl chr22:42,126,499...42,130,865
G
CYP2E1
cytochrome P450 family 2 subfamily E member 1
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CYP2E1 mRNA
CTD
PMID:18544905
NCBI chr10:133,527,363...133,539,123
Ensembl chr10:133,520,406...133,561,220
G
CYP2F1
cytochrome P450 family 2 subfamily F member 1
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CYP2F2 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of CYP2F2 mRNA
CTD
PMID:18544905
NCBI chr19:41,114,432...41,128,381
Ensembl chr19:41,114,432...41,128,381
G
CYP4A22
cytochrome P450 family 4 subfamily A member 22
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CYP4A22 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of CYP4A22 mRNA
CTD
PMID:18544905
NCBI chr 1:47,137,441...47,149,727
Ensembl chr 1:47,137,435...47,149,727
G
CYP4B1
cytochrome P450 family 4 subfamily B member 1
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid] results in decreased expression of CYP4B1 mRNA [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CYP4B1 mRNA
CTD
PMID:17917374 PMID:18544905
NCBI chr 1:46,799,046...46,819,413
Ensembl chr 1:46,757,838...46,819,413
G
CYP4F12
cytochrome P450 family 4 subfamily F member 12
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CYP4F2 mRNA
CTD
PMID:18544905
NCBI chr19:15,673,087...15,697,174
Ensembl chr19:15,673,018...15,697,174
G
CYP7A1
cytochrome P450 family 7 subfamily A member 1
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of CYP7A1 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of CYP7A1 mRNA
CTD
PMID:17917374
NCBI chr 8:58,490,178...58,500,163
Ensembl chr 8:58,490,178...58,500,163
G
CYP8B1
cytochrome P450 family 8 subfamily B member 1
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CYP8B1 mRNA
CTD
PMID:18544905
NCBI chr 3:42,872,192...42,875,879
Ensembl chr 3:42,856,005...42,875,898
G
CYTH3
cytohesin 3
increases expression
EXP
kojic acid results in increased expression of CYTH3 mRNA
CTD
PMID:16595896
NCBI chr 7:6,161,779...6,272,624
Ensembl chr 7:6,161,779...6,272,644
G
CYTIP
cytohesin 1 interacting protein
increases expression
EXP
kojic acid results in increased expression of CYTIP mRNA
CTD
PMID:16595896
NCBI chr 2:157,414,619...157,444,089
Ensembl chr 2:157,414,619...157,488,961
G
DAGLA
diacylglycerol lipase alpha
increases expression
EXP
kojic acid results in increased expression of DAGLA mRNA
CTD
PMID:16595896
NCBI chr11:61,680,391...61,747,001
Ensembl chr11:61,680,391...61,747,001
G
DAZAP2
DAZ associated protein 2
increases expression
EXP
kojic acid results in increased expression of DAZAP2 mRNA
CTD
PMID:16595896
NCBI chr12:51,238,826...51,246,717
Ensembl chr12:51,238,724...51,271,362
G
DCAF13
DDB1 and CUL4 associated factor 13
decreases expression
EXP
kojic acid results in decreased expression of DCAF13 mRNA
CTD
PMID:16595896
NCBI chr 8:103,415,386...103,443,453
Ensembl chr 8:103,414,714...103,443,453
G
DCT
dopachrome tautomerase
decreases expression
ISO
kojic acid results in decreased expression of DCT protein
CTD
PMID:27586645
NCBI chr13:94,436,811...94,549,406
Ensembl chr13:94,436,811...94,479,682
G
DDIT3
DNA damage inducible transcript 3
multiple interactions
ISO
[Ascorbic Acid co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of DDIT3 mRNA
CTD
PMID:18544905
NCBI chr12:57,516,588...57,520,517
Ensembl chr12:57,516,588...57,521,737
G
DEK
DEK proto-oncogene
decreases expression
EXP
kojic acid results in decreased expression of DEK mRNA
CTD
PMID:16595896
NCBI chr 6:18,223,860...18,264,530
Ensembl chr 6:18,223,860...18,264,548
G
DLGAP4
DLG associated protein 4
increases expression
EXP
kojic acid results in increased expression of DLGAP4 mRNA
CTD
PMID:16595896
NCBI chr20:36,306,339...36,528,633
Ensembl chr20:36,306,336...36,528,637
G
DLX1
distal-less homeobox 1
decreases expression
EXP
kojic acid results in decreased expression of DLX1 mRNA
CTD
PMID:16595896
NCBI chr 2:172,085,507...172,089,674
Ensembl chr 2:172,084,740...172,089,677
G
DMXL1
Dmx like 1
decreases expression
EXP
kojic acid results in decreased expression of DMXL1 mRNA
CTD
PMID:16595896
NCBI chr 5:119,071,027...119,249,127
Ensembl chr 5:119,037,772...119,249,138
G
DNAJA1
DnaJ heat shock protein family (Hsp40) member A1
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of DNAJA1 mRNA
CTD
PMID:18544905
NCBI chr 9:33,025,273...33,039,907
Ensembl chr 9:33,025,273...33,039,907
G
DNAJA2
DnaJ heat shock protein family (Hsp40) member A2
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of DNAJA2 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of DNAJA2 mRNA
CTD
PMID:18544905
NCBI chr16:46,955,362...46,973,674
Ensembl chr16:46,955,362...46,973,674
G
DNTTIP2
deoxynucleotidyltransferase terminal interacting protein 2
decreases expression
EXP
kojic acid results in decreased expression of DNTTIP2 mRNA
CTD
PMID:16595896
NCBI chr 1:93,866,284...93,879,206
Ensembl chr 1:93,866,284...93,879,918
G
DOCK4
dedicator of cytokinesis 4
increases expression
EXP
kojic acid results in increased expression of DOCK4 mRNA
CTD
PMID:16595896
NCBI chr 7:111,726,110...112,206,399
Ensembl chr 7:111,726,110...112,206,407
G
DOK4
docking protein 4
decreases expression
EXP
kojic acid results in decreased expression of DOK4 mRNA
CTD
PMID:16595896
NCBI chr16:57,471,922...57,487,322
Ensembl chr16:57,471,922...57,487,327
G
DPYD
dihydropyrimidine dehydrogenase
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid] results in increased expression of DPYD mRNA
CTD
PMID:18544905
NCBI chr 1:97,077,743...97,921,059
Ensembl chr 1:97,077,743...97,995,000
G
DSPP
dentin sialophosphoprotein
decreases expression
EXP
kojic acid results in decreased expression of DSPP mRNA
CTD
PMID:16595896
NCBI chr 4:87,608,529...87,616,873
Ensembl chr 4:87,608,529...87,616,873
G
DSTN
destrin, actin depolymerizing factor
increases expression
EXP
kojic acid results in increased expression of DSTN mRNA
CTD
PMID:16595896
NCBI chr20:17,570,075...17,609,919
Ensembl chr20:17,570,075...17,609,919
G
DYNLT3
dynein light chain Tctex-type 3
decreases expression
EXP
kojic acid results in decreased expression of DYNLT3 mRNA
CTD
PMID:16595896
NCBI chr X:37,838,836...37,847,571
Ensembl chr X:37,836,757...37,847,571
G
E2F3
E2F transcription factor 3
increases expression
EXP
kojic acid results in increased expression of E2F3 mRNA
CTD
PMID:16595896
NCBI chr 6:20,401,879...20,493,714
Ensembl chr 6:20,401,879...20,493,714
G
E2F8
E2F transcription factor 8
increases expression
EXP
kojic acid results in increased expression of E2F8 mRNA
CTD
PMID:16595896
NCBI chr11:19,224,063...19,241,655
Ensembl chr11:19,224,063...19,241,620
G
EFNA3
ephrin A3
decreases expression
EXP
kojic acid results in decreased expression of EFNA3 mRNA
CTD
PMID:16595896
NCBI chr 1:155,078,837...155,087,538
Ensembl chr 1:155,078,837...155,087,538
G
EGR1
early growth response 1
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in increased expression of EGR1 mRNA
CTD
PMID:18544905
NCBI chr 5:138,465,479...138,469,303
Ensembl chr 5:138,465,479...138,469,303
G
EIF4E
eukaryotic translation initiation factor 4E
decreases expression
EXP
kojic acid results in decreased expression of EIF4E mRNA
CTD
PMID:16595896
NCBI chr 4:98,879,276...98,929,133
Ensembl chr 4:98,879,276...98,929,133
G
EIF5A2
eukaryotic translation initiation factor 5A2
increases expression
EXP
kojic acid results in increased expression of EIF5A2 mRNA
CTD
PMID:16595896
NCBI chr 3:170,888,418...170,908,637
Ensembl chr 3:170,888,418...170,908,644
G
ELANE
elastase, neutrophil expressed
decreases expression
EXP
kojic acid results in decreased expression of ELANE mRNA
CTD
PMID:16595896
NCBI chr19:852,303...856,243
Ensembl chr19:851,014...856,247
G
EP300
E1A binding protein p300
increases expression
EXP
kojic acid results in increased expression of EP300 mRNA
CTD
PMID:16595896
NCBI chr22:41,092,592...41,180,077
Ensembl chr22:41,092,592...41,180,077
G
EPHA10
EPH receptor A10
decreases expression
EXP
kojic acid results in decreased expression of EPHA10 mRNA
CTD
PMID:16595896
NCBI chr 1:37,713,880...37,765,120
Ensembl chr 1:37,713,880...37,765,133
G
EPHA4
EPH receptor A4
increases expression
EXP
kojic acid results in increased expression of EPHA4 mRNA
CTD
PMID:16595896
NCBI chr 2:221,418,027...221,574,202
Ensembl chr 2:221,418,027...221,574,202
G
EPHX1
epoxide hydrolase 1
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of EPHX1 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of EPHX1 mRNA
CTD
PMID:18544905
NCBI chr 1:225,810,124...225,845,563
Ensembl chr 1:225,810,124...225,845,563
G
EPHX2
epoxide hydrolase 2
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of EPHX2 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of EPHX2 mRNA
CTD
PMID:18544905
NCBI chr 8:27,491,143...27,548,626
Ensembl chr 8:27,490,781...27,545,564
G
ERCC2
ERCC excision repair 2, TFIIH core complex helicase subunit
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of ERCC2 mRNA
CTD
PMID:17917374
NCBI chr19:45,349,837...45,370,573
Ensembl chr19:45,349,837...45,370,918
G
ERCC3
ERCC excision repair 3, TFIIH core complex helicase subunit
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of ERCC3 mRNA
CTD
PMID:18544905
NCBI chr 2:127,257,290...127,294,144
Ensembl chr 2:127,257,290...127,294,166
G
ERCC4
ERCC excision repair 4, endonuclease catalytic subunit
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of ERCC4 mRNA
CTD
PMID:17917374
NCBI chr16:13,920,154...13,952,348
Ensembl chr16:13,920,138...13,952,348
G
ERCC5
ERCC excision repair 5, endonuclease
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of ERCC5 mRNA
CTD
PMID:17917374
NCBI chr13:102,846,032...102,875,995
Ensembl chr13:102,845,831...102,875,995
G
ESAM
endothelial cell adhesion molecule
increases expression
EXP
kojic acid results in increased expression of ESAM mRNA
CTD
PMID:16595896
NCBI chr11:124,753,126...124,762,290
Ensembl chr11:124,752,583...124,762,290
G
ESRP1
epithelial splicing regulatory protein 1
increases expression
EXP
kojic acid results in increased expression of ESRP1 mRNA
CTD
PMID:16595896
NCBI chr 8:94,641,174...94,707,466
Ensembl chr 8:94,641,074...94,707,466
G
EXD1
exonuclease 3'-5' domain containing 1
decreases expression
EXP
kojic acid results in decreased expression of EXD1 mRNA
CTD
PMID:16595896
NCBI chr15:41,182,728...41,230,757
Ensembl chr15:41,182,725...41,230,757
G
EXOC2
exocyst complex component 2
increases expression
EXP
kojic acid results in increased expression of EXOC2 mRNA
CTD
PMID:16595896
NCBI chr 6:485,154...693,139
Ensembl chr 6:485,154...693,139
G
F10
coagulation factor X
increases expression
EXP
kojic acid results in increased expression of F10 mRNA
CTD
PMID:16595896
NCBI chr13:113,122,799...113,149,529
Ensembl chr13:113,122,799...113,149,529
G
FAM241A
family with sequence similarity 241 member A
increases expression
EXP
kojic acid results in increased expression of FAM241A mRNA
CTD
PMID:16595896
NCBI chr 4:112,145,454...112,195,256
Ensembl chr 4:112,145,454...112,195,256
G
FBN2
fibrillin 2
increases expression
EXP
kojic acid results in increased expression of FBN2 mRNA
CTD
PMID:16595896
NCBI chr 5:128,257,909...128,538,245
Ensembl chr 5:128,257,909...128,659,185
G
FBXO16
F-box protein 16
increases expression
EXP
kojic acid results in increased expression of FBXO16 mRNA
CTD
PMID:16595896
NCBI chr 8:28,428,412...28,490,229
Ensembl chr 8:28,348,287...28,490,278
G
FERRY3
FERRY endosomal RAB5 effector complex subunit 3
decreases expression
EXP
kojic acid results in decreased expression of FERRY3 mRNA
CTD
PMID:16595896
NCBI chr12:4,487,735...4,538,469
Ensembl chr12:4,487,735...4,538,508
G
FGF12
fibroblast growth factor 12
increases expression
EXP
kojic acid results in increased expression of FGF12 mRNA
CTD
PMID:16595896
NCBI chr 3:192,139,390...192,727,541
Ensembl chr 3:192,139,390...192,767,764
G
FGF5
fibroblast growth factor 5
decreases expression
EXP
kojic acid results in decreased expression of FGF5 mRNA
CTD
PMID:16595896
NCBI chr 4:80,266,588...80,291,017
Ensembl chr 4:80,266,639...80,336,680
G
FGFR3
fibroblast growth factor receptor 3
decreases expression
EXP
kojic acid results in decreased expression of FGFR3 mRNA
CTD
PMID:16595896
NCBI chr 4:1,793,293...1,808,867
Ensembl chr 4:1,793,293...1,808,872
G
FIBCD1
fibrinogen C domain containing 1
decreases expression
EXP
kojic acid results in decreased expression of FIBCD1 mRNA
CTD
PMID:16595896
NCBI chr 9:130,902,440...130,940,709
Ensembl chr 9:130,902,438...130,939,286
G
FKBP10
FKBP prolyl isomerase 10
increases expression
EXP
kojic acid results in increased expression of FKBP10 mRNA
CTD
PMID:16595896
NCBI chr17:41,813,004...41,823,213
Ensembl chr17:41,812,680...41,823,213
G
FMO1
flavin containing dimethylaniline monoxygenase 1
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of FMO1 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of FMO1 mRNA
CTD
PMID:18544905
NCBI chr 1:171,248,494...171,285,978
Ensembl chr 1:171,248,471...171,285,978
G
FPGT
fucose-1-phosphate guanylyltransferase
decreases expression
EXP
kojic acid results in decreased expression of FPGT mRNA
CTD
PMID:16595896
NCBI chr 1:74,198,242...74,208,702
Ensembl chr 1:74,198,238...74,234,086
G
FRMPD4
FERM and PDZ domain containing 4
decreases expression
EXP
kojic acid results in decreased expression of FRMPD4 mRNA
CTD
PMID:16595896
NCBI chr X:11,822,439...12,724,523
Ensembl chr X:11,822,423...12,724,523
G
FTH1
ferritin heavy chain 1
increases expression
EXP
kojic acid results in increased expression of FTH1 mRNA; kojic acid results in increased expression of FTH1 protein
CTD
PMID:23738040
NCBI chr11:61,964,285...61,967,634
Ensembl chr11:61,959,718...61,967,634
G
FZD8
frizzled class receptor 8
increases expression
EXP
kojic acid results in increased expression of FZD8 mRNA
CTD
PMID:16595896
NCBI chr10:35,638,247...35,642,296
Ensembl chr10:35,638,247...35,642,296
G
GADD45B
growth arrest and DNA damage inducible beta
multiple interactions
ISO
[Ascorbic Acid co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of GADD45B mRNA
CTD
PMID:18544905
NCBI chr19:2,476,127...2,478,257
Ensembl chr19:2,476,122...2,478,259
G
GALNT1
polypeptide N-acetylgalactosaminyltransferase 1
decreases expression
EXP
kojic acid results in decreased expression of GALNT1 mRNA
CTD
PMID:16595896
NCBI chr18:35,580,922...35,711,834
Ensembl chr18:35,581,117...35,711,834
G
GFOD1
Gfo/Idh/MocA-like oxidoreductase domain containing 1
decreases expression
EXP
kojic acid results in decreased expression of GFOD1 mRNA
CTD
PMID:16595896
NCBI chr 6:13,357,830...13,487,600
Ensembl chr 6:13,357,830...13,487,662
G
GLE1
GLE1 RNA export mediator
decreases expression
EXP
kojic acid results in decreased expression of GLE1 mRNA
CTD
PMID:16595896
NCBI chr 9:128,504,692...128,542,288
Ensembl chr 9:128,504,655...128,543,874
G
GMPR
guanosine monophosphate reductase
decreases expression
EXP
kojic acid results in decreased expression of GMPR mRNA
CTD
PMID:16595896
NCBI chr 6:16,238,587...16,295,549
Ensembl chr 6:16,238,587...16,295,549
G
GNB1
G protein subunit beta 1
increases expression
EXP
kojic acid results in increased expression of GNB1 mRNA
CTD
PMID:16595896
NCBI chr 1:1,785,286...1,891,087
Ensembl chr 1:1,785,285...1,892,292
G
GPR146
G protein-coupled receptor 146
decreases expression
EXP
kojic acid results in decreased expression of GPR146 mRNA
CTD
PMID:16595896
NCBI chr 7:1,044,546...1,059,261
Ensembl chr 7:1,044,546...1,059,261
G
GPR26
G protein-coupled receptor 26
decreases expression
EXP
kojic acid results in decreased expression of GPR26 mRNA
CTD
PMID:16595896
NCBI chr10:123,666,355...123,697,399
Ensembl chr10:123,666,355...123,697,399
G
GPR32
G protein-coupled receptor 32
increases expression
EXP
kojic acid results in increased expression of GPR32 mRNA
CTD
PMID:16595896
NCBI chr19:50,770,464...50,771,732
Ensembl chr19:50,770,464...50,771,732
G
GPR61
G protein-coupled receptor 61
decreases expression
EXP
kojic acid results in decreased expression of GPR61 mRNA
CTD
PMID:16595896
NCBI chr 1:109,539,872...109,547,260
Ensembl chr 1:109,539,872...109,548,406
G
GPX1
glutathione peroxidase 1
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of GPX1 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of GPX1 mRNA
CTD
PMID:18544905
NCBI chr 3:49,357,176...49,358,353
Ensembl chr 3:49,357,174...49,358,605
G
GSDMA
gasdermin A
decreases expression
EXP
kojic acid results in decreased expression of GSDMA mRNA
CTD
PMID:16595896
NCBI chr17:39,963,004...39,977,768
Ensembl chr17:39,953,263...39,977,768
G
GSR
glutathione-disulfide reductase
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of GSR mRNA
CTD
PMID:17917374
NCBI chr 8:30,678,066...30,727,846
Ensembl chr 8:30,678,066...30,727,846
G
GSTA2
glutathione S-transferase alpha 2
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of GSTA2 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of GSTA2 mRNA
CTD
PMID:18544905
NCBI chr 6:52,750,087...52,763,475
Ensembl chr 6:52,750,087...52,763,475
G
GSTA4
glutathione S-transferase alpha 4
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid] results in increased expression of GSTA4 mRNA
CTD
PMID:18544905
NCBI chr 6:52,977,953...52,995,284
Ensembl chr 6:52,977,948...52,995,304
G
GSTM1
glutathione S-transferase mu 1
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of GSTM1 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of GSTM1 mRNA
CTD
PMID:18544905
NCBI chr 1:109,687,817...109,693,745
Ensembl chr 1:109,687,814...109,709,039
G
GSTM2
glutathione S-transferase mu 2
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of GSTM2 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of GSTM2 mRNA
CTD
PMID:18544905
NCBI chr 1:109,668,057...109,683,997
Ensembl chr 1:109,668,022...109,709,551
G
GSTM3
glutathione S-transferase mu 3
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid] results in increased expression of GSTM3 mRNA [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of GSTM3 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of GSTM3 mRNA
CTD
PMID:17917374 PMID:18544905
NCBI chr 1:109,733,937...109,741,038
Ensembl chr 1:109,733,932...109,741,038
G
GUCY1A2
guanylate cyclase 1 soluble subunit alpha 2
decreases expression
EXP
kojic acid results in decreased expression of GUCY1A2 mRNA
CTD
PMID:16595896
NCBI chr11:106,674,019...107,018,476
Ensembl chr11:106,674,019...107,018,476
G
H1-1
H1.1 linker histone, cluster member
increases expression
EXP
kojic acid results in increased expression of H1-1 mRNA
CTD
PMID:16595896
NCBI chr 6:26,017,032...26,017,787
Ensembl chr 6:26,017,032...26,017,787
G
H2AC14
H2A clustered histone 14
increases expression
EXP
kojic acid results in increased expression of H2AC14 mRNA
CTD
PMID:16595896
NCBI chr 6:27,814,302...27,814,777
Ensembl chr 6:27,814,302...27,814,777
G
H2AC6
H2A clustered histone 6
increases expression
EXP
kojic acid results in increased expression of H2AC6 mRNA
CTD
PMID:16595896
NCBI chr 6:26,124,172...26,124,690
Ensembl chr 6:26,124,145...26,139,116
G
HAND1
heart and neural crest derivatives expressed 1
increases expression
EXP
kojic acid results in increased expression of HAND1 mRNA
CTD
PMID:16595896
NCBI chr 5:154,474,972...154,478,227
Ensembl chr 5:154,474,972...154,478,227
G
HARBI1
harbinger transposase derived 1
decreases expression
EXP
kojic acid results in decreased expression of HARBI1 mRNA
CTD
PMID:16595896
NCBI chr11:46,602,861...46,617,895
Ensembl chr11:46,602,861...46,617,909
G
HIBCH
3-hydroxyisobutyryl-CoA hydrolase
decreases expression
EXP
kojic acid results in decreased expression of HIBCH mRNA
CTD
PMID:16595896
NCBI chr 2:190,189,735...190,319,826
Ensembl chr 2:190,189,735...190,344,193
G
HINT3
histidine triad nucleotide binding protein 3
increases expression
EXP
kojic acid results in increased expression of HINT3 mRNA
CTD
PMID:16595896
NCBI chr 6:125,956,770...125,980,244
Ensembl chr 6:125,956,770...125,980,244
G
HIP1
huntingtin interacting protein 1
increases expression
EXP
kojic acid results in increased expression of HIP1 mRNA
CTD
PMID:16595896
NCBI chr 7:75,533,298...75,738,941
Ensembl chr 7:75,533,298...75,738,962
G
HLF
HLF transcription factor, PAR bZIP family member
decreases expression
EXP
kojic acid results in decreased expression of HLF mRNA
CTD
PMID:16595896
NCBI chr17:55,264,960...55,325,187
Ensembl chr17:55,264,960...55,325,187
G
HMMR
hyaluronan mediated motility receptor
decreases expression
EXP
kojic acid results in decreased expression of HMMR mRNA
CTD
PMID:16595896
NCBI chr 5:163,460,632...163,491,941
Ensembl chr 5:163,460,203...163,491,941
G
HMOX2
heme oxygenase 2
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of HMOX2 mRNA
CTD
PMID:18544905
NCBI chr16:4,474,736...4,510,347
Ensembl chr16:4,474,690...4,510,347
G
HNRNPH2
heterogeneous nuclear ribonucleoprotein H2
increases expression
EXP
kojic acid results in increased expression of HNRNPH2 mRNA
CTD
PMID:16595896
NCBI chr X:101,408,222...101,414,133
Ensembl chr X:101,408,222...101,414,133
G
HPS3
HPS3 biogenesis of lysosomal organelles complex 2 subunit 1
decreases expression
EXP
kojic acid results in decreased expression of HPS3 mRNA
CTD
PMID:16595896
NCBI chr 3:149,129,638...149,173,732
Ensembl chr 3:149,129,638...149,173,732
G
HSP90AA1
heat shock protein 90 alpha family class A member 1
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of HSP90AA1 mRNA
CTD
PMID:18544905
NCBI chr14:102,080,742...102,139,749
Ensembl chr14:102,080,742...102,139,699
G
HSP90AB1
heat shock protein 90 alpha family class B member 1
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of HSP90AB1 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of HSP90AB1 mRNA
CTD
PMID:18544905
NCBI chr 6:44,246,194...44,253,883
Ensembl chr 6:44,246,166...44,253,888
G
HSPA1A
heat shock protein family A (Hsp70) member 1A
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of HSPA1A mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of HSPA1A mRNA
CTD
PMID:18544905
NCBI chr 6:31,815,543...31,817,942
Ensembl chr 6:31,815,543...31,817,946
G
HSPA5
heat shock protein family A (Hsp70) member 5
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of HSPA5 mRNA
CTD
PMID:18544905
NCBI chr 9:125,234,853...125,241,343
Ensembl chr 9:125,234,853...125,241,382
G
HSPB1
heat shock protein family B (small) member 1
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of HSPB1 mRNA
CTD
PMID:18544905
NCBI chr 7:76,302,673...76,304,292
Ensembl chr 7:76,302,673...76,304,295
G
HSPD1
heat shock protein family D (Hsp60) member 1
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of HSPD1 mRNA
CTD
PMID:18544905
NCBI chr 2:197,486,584...197,500,274
Ensembl chr 2:197,486,584...197,516,737
G
HSPE1
heat shock protein family E (Hsp10) member 1
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of HSPE1 mRNA [Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of HSPE1 mRNA
CTD
PMID:17917374 PMID:18544905
NCBI chr 2:197,500,379...197,503,449
Ensembl chr 2:197,500,140...197,503,449
G
HYOU1
hypoxia up-regulated 1
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of HYOU1 mRNA
CTD
PMID:18544905
NCBI chr11:119,044,188...119,057,205
Ensembl chr11:119,044,188...119,057,227
G
IGF2R
insulin like growth factor 2 receptor
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of IGF2R mRNA
CTD
PMID:18544905
NCBI chr 6:159,969,082...160,111,504
Ensembl chr 6:159,969,082...160,113,507
G
IL1A
interleukin 1 alpha
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid] results in decreased expression of IL1A mRNA
CTD
PMID:18544905
NCBI chr 2:112,773,925...112,784,493
Ensembl chr 2:112,773,925...112,784,493
G
IL1B
interleukin 1 beta
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid] results in decreased expression of IL1B mRNA
CTD
PMID:18544905
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
G
IL1RL1
interleukin 1 receptor like 1
increases expression
ISO
kojic acid results in increased expression of IL1RL1 mRNA
CTD
PMID:19000923
NCBI chr 2:102,311,563...102,352,356
Ensembl chr 2:102,311,502...102,352,037
G
IL22RA1
interleukin 22 receptor subunit alpha 1
increases expression
EXP
kojic acid results in increased expression of IL22RA1 mRNA
CTD
PMID:16595896
NCBI chr 1:24,119,771...24,143,140
Ensembl chr 1:24,119,771...24,143,140
G
IL6
interleukin 6
decreases expression
EXP
kojic acid results in decreased expression of IL6 protein
CTD
PMID:12727023
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
G
IL6ST
interleukin 6 cytokine family signal transducer
decreases expression
EXP
kojic acid results in decreased expression of IL6ST mRNA
CTD
PMID:16595896
NCBI chr 5:55,935,095...55,994,963
Ensembl chr 5:55,935,095...55,995,022
G
INCENP
inner centromere protein
increases expression
EXP
kojic acid results in increased expression of INCENP mRNA
CTD
PMID:16595896
NCBI chr11:62,124,011...62,153,169
Ensembl chr11:62,123,998...62,153,169
G
JUN
Jun proto-oncogene, AP-1 transcription factor subunit
increases expression
ISO
kojic acid results in increased expression of JUN mRNA
CTD
PMID:19000923
NCBI chr 1:58,780,791...58,784,047
Ensembl chr 1:58,776,845...58,784,048
G
KARS1
lysyl-tRNA synthetase 1
decreases expression
EXP
kojic acid results in decreased expression of KARS1 mRNA
CTD
PMID:16595896
NCBI chr16:75,627,724...75,647,665
Ensembl chr16:75,627,474...75,648,643
G
KCNAB3
potassium voltage-gated channel subfamily A regulatory beta subunit 3
decreases expression
EXP
kojic acid results in decreased expression of KCNAB3 mRNA
CTD
PMID:16595896
NCBI chr17:7,921,859...7,929,856
Ensembl chr17:7,921,859...7,929,856
G
KCTD17
potassium channel tetramerization domain containing 17
decreases expression
EXP
kojic acid results in decreased expression of KCTD17 mRNA
CTD
PMID:16595896
NCBI chr22:37,051,742...37,063,390
Ensembl chr22:37,051,739...37,063,390
G
KDM4D
lysine demethylase 4D
increases expression
EXP
kojic acid results in increased expression of KDM4D mRNA
CTD
PMID:16595896
NCBI chr11:94,973,709...94,999,519
Ensembl chr11:94,973,709...94,999,519
G
KLF5
KLF transcription factor 5
increases expression
EXP
kojic acid results in increased expression of KLF5 mRNA
CTD
PMID:16595896
NCBI chr13:73,054,976...73,077,538
Ensembl chr13:73,054,976...73,077,541
G
KLHL13
kelch like family member 13
increases expression
EXP
kojic acid results in increased expression of KLHL13 mRNA
CTD
PMID:16595896
NCBI chr X:117,897,813...118,117,340
Ensembl chr X:117,897,813...118,117,340
G
KLKB1
kallikrein B1
decreases expression
EXP
kojic acid results in decreased expression of KLKB1 mRNA
CTD
PMID:16595896
NCBI chr 4:186,210,853...186,258,471
Ensembl chr 4:186,226,438...186,258,471
G
KRT7
keratin 7
increases expression
EXP
kojic acid results in increased expression of KRT7 mRNA
CTD
PMID:16595896
NCBI chr12:52,233,243...52,255,853
Ensembl chr12:52,232,520...52,252,186
G
KTN1
kinectin 1
decreases expression
EXP
kojic acid results in decreased expression of KTN1 mRNA
CTD
PMID:16595896
NCBI chr14:55,580,207...55,684,584
Ensembl chr14:55,559,072...55,701,526
G
LARP7
La ribonucleoprotein 7, transcriptional regulator
decreases expression
EXP
kojic acid results in decreased expression of LARP7 mRNA
CTD
PMID:16595896
NCBI chr 4:112,637,143...112,657,586
Ensembl chr 4:112,637,077...112,657,696
G
LILRB5
leukocyte immunoglobulin like receptor B5
decreases expression
EXP
kojic acid results in decreased expression of LILRB5 mRNA
CTD
PMID:16595896
NCBI chr19:54,249,421...54,257,273
Ensembl chr19:54,249,421...54,257,301
G
LRP6
LDL receptor related protein 6
decreases expression
EXP
kojic acid results in decreased expression of LRP6 mRNA
CTD
PMID:16595896
NCBI chr12:12,116,025...12,267,044
Ensembl chr12:12,116,025...12,267,044
G
LRRC4
leucine rich repeat containing 4
decreases expression
EXP
kojic acid results in decreased expression of LRRC4 mRNA
CTD
PMID:16595896
NCBI chr 7:128,027,071...128,032,128
Ensembl chr 7:128,027,071...128,032,107
G
LRRC9
leucine rich repeat containing 9
increases expression
EXP
kojic acid results in increased expression of LRRC9 mRNA
CTD
PMID:16595896
NCBI chr14:59,919,713...60,066,817
Ensembl chr14:59,919,713...60,066,817
G
MAEA
macrophage erythroblast attacher, E3 ubiquitin ligase
increases expression
EXP
kojic acid results in increased expression of MAEA mRNA
CTD
PMID:16595896
NCBI chr 4:1,289,891...1,340,137
Ensembl chr 4:1,289,887...1,340,147
G
MAFK
MAF bZIP transcription factor K
decreases expression
EXP
kojic acid results in decreased expression of MAFK mRNA
CTD
PMID:16595896
NCBI chr 7:1,530,702...1,543,043
Ensembl chr 7:1,530,702...1,543,043
G
MAGEC2
MAGE family member C2
increases expression
EXP
kojic acid results in increased expression of MAGEC2 mRNA
CTD
PMID:16595896
NCBI chr X:142,202,342...142,205,290
Ensembl chr X:142,202,342...142,205,290
G
MAGEF1
MAGE family member F1
increases expression
EXP
kojic acid results in increased expression of MAGEF1 mRNA
CTD
PMID:16595896
NCBI chr 3:184,710,364...184,712,064
Ensembl chr 3:184,710,364...184,712,064
G
MAOA
monoamine oxidase A
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of MAOA mRNA
CTD
PMID:18544905
NCBI chr X:43,655,006...43,746,817
Ensembl chr X:43,654,907...43,746,817
G
MAOB
monoamine oxidase B
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of MAOB mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of MAOB mRNA
CTD
PMID:18544905
NCBI chr X:43,766,610...43,882,450
Ensembl chr X:43,766,610...43,882,450
G
MAP7D2
MAP7 domain containing 2
decreases expression
EXP
kojic acid results in decreased expression of MAP7D2 mRNA
CTD
PMID:16595896
NCBI chr X:20,006,713...20,116,907
Ensembl chr X:20,006,713...20,116,907
G
MAPK1
mitogen-activated protein kinase 1
decreases phosphorylation
ISO
kojic acid results in decreased phosphorylation of MAPK1 protein
CTD
PMID:27586645
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
G
MAPK3
mitogen-activated protein kinase 3
decreases phosphorylation
ISO
kojic acid results in decreased phosphorylation of MAPK3 protein
CTD
PMID:27586645
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
G
MAPK8
mitogen-activated protein kinase 8
decreases expression
EXP
kojic acid results in decreased expression of MAPK8 mRNA
CTD
PMID:16595896
NCBI chr10:48,306,677...48,439,360
Ensembl chr10:48,306,639...48,439,360
G
MBNL1
muscleblind like splicing regulator 1
decreases expression
EXP
kojic acid results in decreased expression of MBNL1 mRNA
CTD
PMID:16595896
NCBI chr 3:152,243,632...152,465,780
Ensembl chr 3:152,243,828...152,465,780
G
MC1R
melanocortin 1 receptor
decreases expression increases expression
ISO EXP
kojic acid results in decreased expression of MC1R protein kojic acid results in increased expression of MC1R protein
CTD
PMID:23738040 PMID:27586645
NCBI chr16:89,918,862...89,920,972
Ensembl chr16:89,912,119...89,920,973
G
MDFI
MyoD family inhibitor
decreases expression
EXP
kojic acid results in decreased expression of MDFI mRNA
CTD
PMID:16595896
NCBI chr 6:41,637,018...41,654,244
Ensembl chr 6:41,636,882...41,654,244
G
MDM2
MDM2 proto-oncogene
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of MDM2 mRNA
CTD
PMID:18544905
NCBI chr12:68,808,172...68,850,686
Ensembl chr12:68,808,177...68,845,544
G
ME3
malic enzyme 3
decreases expression
EXP
kojic acid results in decreased expression of ME3 mRNA
CTD
PMID:16595896
NCBI chr11:86,434,930...86,672,616
Ensembl chr11:86,441,108...86,672,636
G
MED14
mediator complex subunit 14
increases expression
EXP
kojic acid results in increased expression of MED14 mRNA
CTD
PMID:16595896
NCBI chr X:40,648,305...40,736,159
Ensembl chr X:40,648,305...40,735,858
G
MEX3B
mex-3 RNA binding family member B
increases expression
EXP
kojic acid results in increased expression of MEX3B mRNA
CTD
PMID:16595896
NCBI chr15:82,041,778...82,046,018
Ensembl chr15:82,041,778...82,046,119
G
MFAP4
microfibril associated protein 4
decreases expression
EXP
kojic acid results in decreased expression of MFAP4 mRNA
CTD
PMID:16595896
NCBI chr17:19,383,445...19,387,190
Ensembl chr17:19,383,442...19,387,190
G
MGMT
O-6-methylguanine-DNA methyltransferase
multiple interactions
ISO
[kojic acid co-treated with Diethylnitrosamine] results in increased expression of MGMT mRNA; Ascorbic Acid inhibits the reaction [[kojic acid co-treated with Diethylnitrosamine] results in increased expression of MGMT mRNA]
CTD
PMID:18544905
NCBI chr10:129,467,241...129,770,983
Ensembl chr10:129,467,190...129,770,983
G
MGST1
microsomal glutathione S-transferase 1
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of MGST1 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of MGST1 mRNA
CTD
PMID:18544905
NCBI chr12:16,347,115...16,593,331
Ensembl chr12:16,347,142...16,609,259
G
MIDN
midnolin
decreases expression
EXP
kojic acid results in decreased expression of MIDN mRNA
CTD
PMID:16595896
NCBI chr19:1,248,583...1,259,143
Ensembl chr19:1,248,553...1,259,143
G
MIF
macrophage migration inhibitory factor
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of MIF mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of MIF mRNA
CTD
PMID:18544905
NCBI chr22:23,894,383...23,895,223
Ensembl chr22:23,894,383...23,895,227
G
MND1
meiotic nuclear divisions 1
increases expression
EXP
kojic acid results in increased expression of GAJ mRNA
CTD
PMID:16595896
NCBI chr 4:153,344,649...153,415,118
Ensembl chr 4:153,344,649...153,415,118
G
MRPL30
mitochondrial ribosomal protein L30
decreases expression
EXP
kojic acid results in decreased expression of MRPL30 mRNA
CTD
PMID:16595896
NCBI chr 2:99,181,184...99,199,561
Ensembl chr 2:99,181,152...99,199,561
G
MT-CO1
mitochondrially encoded cytochrome c oxidase I
increases expression
EXP
kojic acid results in increased expression of COX1 mRNA; kojic acid results in increased expression of COX1 protein
CTD
PMID:23738040
NCBI chr MT:5,904...7,445
Ensembl chr MT:5,904...7,445
G
MTREX
Mtr4 exosome RNA helicase
decreases expression
EXP
kojic acid results in decreased expression of MTREX mRNA
CTD
PMID:16595896
NCBI chr 5:55,307,989...55,425,579
Ensembl chr 5:55,307,989...55,425,579
G
MVP
major vault protein
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of MVP mRNA
CTD
PMID:18544905
NCBI chr16:29,820,394...29,848,039
Ensembl chr16:29,820,394...29,848,039
G
NAA25
N-alpha-acetyltransferase 25, NatB auxiliary subunit
increases expression
EXP
kojic acid results in increased expression of NAA25 mRNA
CTD
PMID:16595896
NCBI chr12:112,026,689...112,108,783
Ensembl chr12:112,026,689...112,108,796
G
NCALD
neurocalcin delta
decreases expression
EXP
kojic acid results in decreased expression of NCALD mRNA
CTD
PMID:16595896
NCBI chr 8:101,686,542...102,124,907
Ensembl chr 8:101,686,542...102,124,907
G
NDUFA1
NADH:ubiquinone oxidoreductase subunit A1
increases expression
EXP
kojic acid results in increased expression of NDUFA1 mRNA
CTD
PMID:16595896
NCBI chr X:119,871,832...119,876,662
Ensembl chr X:119,871,832...119,876,662
G
NECTIN4
nectin cell adhesion molecule 4
increases expression
EXP
kojic acid results in increased expression of NECTIN4 mRNA
CTD
PMID:16595896
NCBI chr 1:161,070,998...161,089,558
Ensembl chr 1:161,070,998...161,089,558
G
NFIL3
nuclear factor, interleukin 3 regulated
increases expression
EXP
kojic acid results in increased expression of NFIL3 mRNA
CTD
PMID:16595896
NCBI chr 9:91,409,045...91,483,497
Ensembl chr 9:91,409,045...91,423,832
G
NFKBIA
NFKB inhibitor alpha
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of NFKBIA mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of NFKBIA mRNA
CTD
PMID:18544905
NCBI chr14:35,401,513...35,404,749
Ensembl chr14:35,401,079...35,404,749
G
NFKBIE
NFKB inhibitor epsilon
increases expression
EXP
kojic acid results in increased expression of NFKBIE mRNA
CTD
PMID:16595896
NCBI chr 6:44,258,166...44,265,551
Ensembl chr 6:44,258,166...44,265,788
G
NKX6-1
NK6 homeobox 1
decreases expression
EXP
kojic acid results in decreased expression of NKX6-1 mRNA
CTD
PMID:16595896
NCBI chr 4:84,491,985...84,499,292
Ensembl chr 4:84,491,985...84,499,292
G
NLGN2
neuroligin 2
decreases expression
EXP
kojic acid results in decreased expression of NLGN2 mRNA
CTD
PMID:16595896
NCBI chr17:7,404,653...7,419,860
Ensembl chr17:7,404,874...7,419,860
G
NOC3L
NOC3 like DNA replication regulator
decreases expression
EXP
kojic acid results in decreased expression of NOC3L mRNA
CTD
PMID:16595896
NCBI chr10:94,314,907...94,362,939
Ensembl chr10:94,333,226...94,362,959
G
NOL11
nucleolar protein 11
decreases expression
EXP
kojic acid results in decreased expression of NOL11 mRNA
CTD
PMID:16595896
NCBI chr17:67,717,936...67,744,531
Ensembl chr17:67,717,931...67,744,531
G
NR1I2
nuclear receptor subfamily 1 group I member 2
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of NR1I2 mRNA
CTD
PMID:18544905
NCBI chr 3:119,782,101...119,818,487
Ensembl chr 3:119,780,484...119,818,487
G
NR1I3
nuclear receptor subfamily 1 group I member 3
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of NR1I3 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of NR1I3 mRNA
CTD
PMID:18544905
NCBI chr 1:161,229,669...161,238,203
Ensembl chr 1:161,229,666...161,238,244
G
NUDT10
nudix hydrolase 10
decreases expression
EXP
kojic acid results in decreased expression of NUDT10 mRNA
CTD
PMID:16595896
NCBI chr X:51,332,231...51,337,525
Ensembl chr X:51,332,231...51,337,525
G
ODAD2
outer dynein arm docking complex subunit 2
increases expression
EXP
kojic acid results in increased expression of ODAD2 mRNA
CTD
PMID:16595896
NCBI chr10:27,812,168...27,999,675
Ensembl chr10:27,775,186...27,999,079
G
OLFML1
olfactomedin like 1
decreases expression
EXP
kojic acid results in decreased expression of OLFML1 mRNA
CTD
PMID:16595896
NCBI chr11:7,485,506...7,511,377
Ensembl chr11:7,485,388...7,511,377
G
OR51B4
olfactory receptor family 51 subfamily B member 4
decreases expression
EXP
kojic acid results in decreased expression of OR51B4 mRNA
CTD
PMID:16595896
NCBI chr11:5,301,014...5,301,946
Ensembl chr11:5,301,014...5,301,946
G
OSBP2
oxysterol binding protein 2
decreases expression
EXP
kojic acid results in decreased expression of OSBP2 mRNA
CTD
PMID:16595896
NCBI chr22:30,693,782...30,907,813
Ensembl chr22:30,693,782...30,907,824
G
OSTM1
osteoclastogenesis associated transmembrane protein 1
decreases expression
EXP
kojic acid results in decreased expression of OSTM1 mRNA
CTD
PMID:16595896
NCBI chr 6:108,041,409...108,074,741
Ensembl chr 6:108,029,245...108,165,854
G
OTX1
orthodenticle homeobox 1
increases expression
EXP
kojic acid results in increased expression of OTX1 mRNA
CTD
PMID:16595896
NCBI chr 2:63,049,735...63,057,831
Ensembl chr 2:63,050,057...63,057,836
G
PABIR1
PP2A Aalpha (PPP2R1A) and B55A (PPP2R2A) interacting phosphatase regulator 1
increases expression
EXP
kojic acid results in increased expression of PABIR1 mRNA
CTD
PMID:16595896
NCBI chr 9:68,780,065...68,785,566
Ensembl chr 9:68,780,065...68,785,566
G
PAGR1
PAXIP1 associated glutamate rich protein 1
increases expression
EXP
kojic acid results in increased expression of PAGR1 mRNA
CTD
PMID:16595896
NCBI chr16:29,816,152...29,822,489
Ensembl chr16:29,816,152...29,822,489
G
PAH
phenylalanine hydroxylase
decreases expression
EXP
kojic acid results in decreased expression of PAH mRNA
CTD
PMID:16595896
NCBI chr12:102,836,889...102,958,441
Ensembl chr12:102,836,889...102,958,410
G
PARG
poly(ADP-ribose) glycohydrolase
increases expression
EXP
kojic acid results in increased expression of PARG mRNA
CTD
PMID:16595896
NCBI chr10:49,818,279...49,942,027
Ensembl chr10:49,818,279...49,970,203
G
PBK
PDZ binding kinase
decreases expression
EXP
kojic acid results in decreased expression of PBK mRNA
CTD
PMID:16595896
NCBI chr 8:27,809,624...27,837,817
Ensembl chr 8:27,809,624...27,838,082
G
PCNA
proliferating cell nuclear antigen
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of PCNA protein [Ascorbic Acid co-treated with kojic acid co-treated with Diethylnitrosamine] results in increased expression of PCNA protein
CTD
PMID:17917374 PMID:18544905
NCBI chr20:5,114,953...5,126,622
Ensembl chr20:5,114,953...5,126,626
G
PCNX3
pecanex 3
decreases expression
EXP
kojic acid results in decreased expression of PCNX3 mRNA
CTD
PMID:16595896
NCBI chr11:65,615,776...65,637,439
Ensembl chr11:65,615,776...65,637,439
G
PCSK4
proprotein convertase subtilisin/kexin type 4
decreases expression
EXP
kojic acid results in decreased expression of PCSK4 mRNA
CTD
PMID:16595896
NCBI chr19:1,481,428...1,490,876
Ensembl chr19:1,481,428...1,490,752
G
PDCL
phosducin like
increases expression
EXP
kojic acid results in increased expression of PDCL mRNA
CTD
PMID:16595896
NCBI chr 9:122,818,097...122,828,588
Ensembl chr 9:122,798,389...122,828,588
G
PDHA1
pyruvate dehydrogenase E1 subunit alpha 1
increases expression
EXP
kojic acid results in increased expression of PDHA1 mRNA
CTD
PMID:16595896
NCBI chr X:19,343,927...19,361,718
Ensembl chr X:19,343,893...19,361,718
G
PDIA3
protein disulfide isomerase family A member 3
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of PDIA3 mRNA
CTD
PMID:18544905
NCBI chr15:43,746,438...43,773,278
Ensembl chr15:43,746,394...43,773,279
G
PDLIM2
PDZ and LIM domain 2
increases expression
EXP
kojic acid results in increased expression of PDLIM2 mRNA
CTD
PMID:16595896
NCBI chr 8:22,578,741...22,598,026
Ensembl chr 8:22,578,279...22,598,025
G
PERM1
PPARGC1 and ESRR induced regulator, muscle 1
decreases expression
EXP
kojic acid results in decreased expression of PERM1 mRNA
CTD
PMID:16595896
NCBI chr 1:975,198...982,093
Ensembl chr 1:975,198...982,117
G
PEX5L
peroxisomal biogenesis factor 5 like
decreases expression
EXP
kojic acid results in decreased expression of PEX5L mRNA
CTD
PMID:16595896
NCBI chr 3:179,794,958...180,036,937
Ensembl chr 3:179,794,958...180,037,053
G
PGM2
phosphoglucomutase 2
increases expression
EXP
kojic acid results in increased expression of PGM2 mRNA
CTD
PMID:16595896
NCBI chr 4:37,826,686...37,862,937
Ensembl chr 4:37,826,660...37,862,937
G
PIGQ
phosphatidylinositol glycan anchor biosynthesis class Q
decreases expression
EXP
kojic acid results in decreased expression of PIGQ mRNA
CTD
PMID:16595896
NCBI chr16:569,968...584,109
Ensembl chr16:566,995...584,109
G
PITPNB
phosphatidylinositol transfer protein beta
increases expression
EXP
kojic acid results in increased expression of PITPNB mRNA
CTD
PMID:16595896
NCBI chr22:27,851,669...27,919,256
Ensembl chr22:27,851,669...27,920,134
G
PLAGL1
PLAG1 like zinc finger 1
increases expression
EXP
kojic acid results in increased expression of PLAGL1 mRNA
CTD
PMID:16595896
NCBI chr 6:143,940,300...144,064,599
Ensembl chr 6:143,940,300...144,064,599
G
POGLUT2
protein O-glucosyltransferase 2
increases expression
EXP
kojic acid results in increased expression of POGLUT2 mRNA
CTD
PMID:16595896
NCBI chr13:102,784,281...102,798,976
Ensembl chr13:102,784,281...102,799,040
G
PON3
paraoxonase 3
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of PON3 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of PON3 mRNA
CTD
PMID:18544905
NCBI chr 7:95,359,872...95,396,375
Ensembl chr 7:95,359,872...95,396,375
G
POR
cytochrome p450 oxidoreductase
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of POR mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of POR mRNA
CTD
PMID:18544905
NCBI chr 7:75,915,155...75,986,855
Ensembl chr 7:75,899,200...75,986,855
G
POU2F3
POU class 2 homeobox 3
decreases expression
EXP
kojic acid results in decreased expression of POU2F3 mRNA
CTD
PMID:16595896
NCBI chr11:120,236,638...120,319,945
Ensembl chr11:120,236,640...120,319,945
G
PPP4R1
protein phosphatase 4 regulatory subunit 1
increases expression
EXP
kojic acid results in increased expression of PPP4R1 mRNA
CTD
PMID:16595896
NCBI chr18:9,546,794...9,617,199
Ensembl chr18:9,546,791...9,615,240
G
PRDX1
peroxiredoxin 1
multiple interactions
ISO
[Ascorbic Acid co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of PRDX1 mRNA
CTD
PMID:18544905
NCBI chr 1:45,511,051...45,522,890
Ensembl chr 1:45,510,914...45,542,732
G
PRDX2
peroxiredoxin 2
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of PRDX2 mRNA
CTD
PMID:18544905
NCBI chr19:12,796,823...12,801,800
Ensembl chr19:12,796,820...12,801,800
G
PRG2
proteoglycan 2, pro eosinophil major basic protein
decreases expression
EXP
kojic acid results in decreased expression of PRG2 mRNA
CTD
PMID:16595896
NCBI chr11:57,386,780...57,390,650
Ensembl chr11:57,386,780...57,390,650
G
PRICKLE3
prickle planar cell polarity protein 3
decreases expression
EXP
kojic acid results in decreased expression of PRICKLE3 mRNA
CTD
PMID:16595896
NCBI chr X:49,174,802...49,186,373
Ensembl chr X:49,174,802...49,186,528
G
PRIM1
DNA primase subunit 1
decreases expression
EXP
kojic acid results in decreased expression of PRIM1 mRNA
CTD
PMID:16595896
NCBI chr12:56,731,580...56,752,323
Ensembl chr12:56,730,438...56,752,374
G
PRMT2
protein arginine methyltransferase 2
decreases expression
EXP
kojic acid results in decreased expression of PRMT2 mRNA
CTD
PMID:16595896
NCBI chr21:46,635,674...46,665,124
Ensembl chr21:46,635,595...46,665,124
G
PRPF40A
pre-mRNA processing factor 40 homolog A
decreases expression
EXP
kojic acid results in decreased expression of PRPF40A mRNA
CTD
PMID:16595896
NCBI chr 2:152,651,732...152,718,019
Ensembl chr 2:152,651,593...152,718,012
G
PRPS2
phosphoribosyl pyrophosphate synthetase 2
increases expression
EXP
kojic acid results in increased expression of PRPS2 mRNA
CTD
PMID:16595896
NCBI chr X:12,791,412...12,824,222
Ensembl chr X:12,791,355...12,824,222
G
PRR18
proline rich 18
decreases expression
EXP
kojic acid results in decreased expression of PRR18 mRNA
CTD
PMID:16595896
NCBI chr 6:166,305,300...166,308,392
Ensembl chr 6:166,305,300...166,308,448
G
PRRC2C
proline rich coiled-coil 2C
increases expression
EXP
kojic acid results in increased expression of PRRC2C mRNA
CTD
PMID:16595896
NCBI chr 1:171,485,530...171,593,511
Ensembl chr 1:171,485,530...171,593,511
G
PRRX1
paired related homeobox 1
decreases expression
EXP
kojic acid results in decreased expression of PRRX1 mRNA
CTD
PMID:16595896
NCBI chr 1:170,662,768...170,739,421
Ensembl chr 1:170,662,728...170,739,421
G
PSMC6
proteasome 26S subunit, ATPase 6
decreases expression
EXP
kojic acid results in decreased expression of PSMC6 mRNA
CTD
PMID:16595896
NCBI chr14:52,707,200...52,728,590
Ensembl chr14:52,707,178...52,728,590
G
PSMD3
proteasome 26S subunit, non-ATPase 3
decreases expression
EXP
kojic acid results in decreased expression of PSMD3 mRNA
CTD
PMID:16595896
NCBI chr17:39,980,807...39,997,959
Ensembl chr17:39,980,807...39,997,959
G
PTMAP7
prothymosin alpha pseudogene 7
increases expression
EXP
kojic acid results in increased expression of PTMAP7 mRNA
CTD
PMID:16595896
NCBI chr14:92,026,422...92,027,567
G
PUS7L
pseudouridine synthase 7 like
decreases expression
EXP
kojic acid results in decreased expression of PUS7L mRNA
CTD
PMID:16595896
NCBI chr12:43,718,992...43,758,790
Ensembl chr12:43,718,992...43,758,793
G
RAB3GAP1
RAB3 GTPase activating protein catalytic subunit 1
increases expression
EXP
kojic acid results in increased expression of RAB3GAP1 mRNA
CTD
PMID:16595896
NCBI chr 2:135,052,292...135,176,396
Ensembl chr 2:135,052,289...135,176,667
G
RAB6B
RAB6B, member RAS oncogene family
decreases expression
EXP
kojic acid results in decreased expression of RAB6B mRNA
CTD
PMID:16595896
NCBI chr 3:133,824,235...133,895,882
Ensembl chr 3:133,824,235...133,895,882
G
RAD1
RAD1 checkpoint DNA exonuclease
increases expression
EXP
kojic acid results in increased expression of RAD1 mRNA
CTD
PMID:16595896
NCBI chr 5:34,905,260...34,915,504
Ensembl chr 5:34,905,260...34,918,989
G
RAD23A
RAD23 homolog A, nucleotide excision repair protein
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of RAD23A mRNA
CTD
PMID:18544905
NCBI chr19:12,945,862...12,953,642
Ensembl chr19:12,945,855...12,953,642
G
RAD50
RAD50 double strand break repair protein
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of RAD50 mRNA
CTD
PMID:17917374
NCBI chr 5:132,556,977...132,646,349
Ensembl chr 5:132,556,019...132,646,349
G
RARA
retinoic acid receptor alpha
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of RARA mRNA
CTD
PMID:18544905
NCBI chr17:40,309,180...40,357,643
Ensembl chr17:40,309,180...40,357,643
G
RARB
retinoic acid receptor beta
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of RARB mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of RARB mRNA
CTD
PMID:18544905
NCBI chr 3:24,829,321...25,597,932
Ensembl chr 3:24,687,887...25,597,932
G
RASD1
ras related dexamethasone induced 1
increases expression
EXP
kojic acid results in increased expression of RASD1 mRNA
CTD
PMID:16595896
NCBI chr17:17,494,437...17,496,395
Ensembl chr17:17,494,437...17,496,395
G
RASGEF1B
RasGEF domain family member 1B
decreases expression
EXP
kojic acid results in decreased expression of RASGEF1B mRNA
CTD
PMID:16595896
NCBI chr 4:81,426,393...81,471,907
Ensembl chr 4:81,426,393...82,044,244
G
RASSF3
Ras association domain family member 3
increases expression
EXP
kojic acid results in increased expression of RASSF3 mRNA
CTD
PMID:16595896
NCBI chr12:64,506,964...64,697,564
Ensembl chr12:64,507,001...64,697,564
G
RB1CC1
RB1 inducible coiled-coil 1
decreases expression
EXP
kojic acid results in decreased expression of RB1CC1 mRNA
CTD
PMID:16595896
NCBI chr 8:52,622,458...52,714,435
Ensembl chr 8:52,622,458...52,745,843
G
RBM38
RNA binding motif protein 38
decreases expression
EXP
kojic acid results in decreased expression of RBM38 mRNA
CTD
PMID:16595896
NCBI chr20:57,391,396...57,409,333
Ensembl chr20:57,391,396...57,409,333
G
RECQL
RecQ like helicase
decreases expression
EXP
kojic acid results in decreased expression of RECQL mRNA
CTD
PMID:16595896
NCBI chr12:21,468,910...21,501,635
Ensembl chr12:21,468,910...21,501,669
G
RIMS2
regulating synaptic membrane exocytosis 2
decreases expression
EXP
kojic acid results in decreased expression of RIMS2 mRNA
CTD
PMID:16595896
NCBI chr 8:103,500,610...104,256,094
Ensembl chr 8:103,500,610...104,254,430
G
RSBN1
round spermatid basic protein 1
decreases expression
EXP
kojic acid results in decreased expression of RSBN1 mRNA
CTD
PMID:16595896
NCBI chr 1:113,761,832...113,812,476
Ensembl chr 1:113,761,832...113,812,476
G
SAA4
serum amyloid A4, constitutive
decreases expression
EXP
kojic acid results in decreased expression of SAA4 mRNA
CTD
PMID:16595896
NCBI chr11:18,231,355...18,236,802
Ensembl chr11:18,231,355...18,236,802
G
SCARB1
scavenger receptor class B member 1
increases expression
ISO
kojic acid results in increased expression of SCARB1 mRNA
CTD
PMID:19000923
NCBI chr12:124,776,856...124,863,864
Ensembl chr12:124,776,856...124,882,668
G
SCN10A
sodium voltage-gated channel alpha subunit 10
decreases expression
EXP
kojic acid results in decreased expression of SCN10A mRNA
CTD
PMID:16595896
NCBI chr 3:38,696,807...38,816,217
Ensembl chr 3:38,696,802...38,816,286
G
SCP2
sterol carrier protein 2
decreases expression
EXP
kojic acid results in decreased expression of SCP2 mRNA
CTD
PMID:16595896
NCBI chr 1:52,927,276...53,051,698
Ensembl chr 1:52,927,276...53,051,698
G
SDC4
syndecan 4
decreases expression
EXP
kojic acid results in decreased expression of SDC4 mRNA
CTD
PMID:16595896
NCBI chr20:45,325,288...45,348,424
Ensembl chr20:45,325,288...45,348,424
G
SEC24B
SEC24 homolog B, COPII coat complex component
increases expression
EXP
kojic acid results in increased expression of SEC24B mRNA
CTD
PMID:16595896
NCBI chr 4:109,433,815...109,540,896
Ensembl chr 4:109,433,772...109,540,896
G
SEC62
SEC62 homolog, preprotein translocation factor
decreases expression
EXP
kojic acid results in decreased expression of SEC62 mRNA
CTD
PMID:16595896
NCBI chr 3:169,966,807...169,998,373
Ensembl chr 3:169,966,635...169,998,373
G
SECTM1
secreted and transmembrane 1
decreases expression
EXP
kojic acid results in decreased expression of SECTM1 mRNA
CTD
PMID:16595896
NCBI chr17:82,321,024...82,333,959
Ensembl chr17:82,321,024...82,334,074
G
SEPTIN7
septin 7
decreases expression
EXP
kojic acid results in decreased expression of SEPTIN7 mRNA
CTD
PMID:16595896
NCBI chr 7:35,800,986...35,915,763
Ensembl chr 7:35,800,932...35,907,110
G
SERPINA5
serpin family A member 5
decreases expression
EXP
kojic acid results in decreased expression of SERPINA5 mRNA
CTD
PMID:16595896
NCBI chr14:94,581,426...94,593,118
Ensembl chr14:94,561,442...94,593,118
G
SHCBP1
SHC binding and spindle associated 1
increases expression
EXP
kojic acid results in increased expression of SHCBP1 mRNA
CTD
PMID:16595896
NCBI chr16:46,578,591...46,621,379
Ensembl chr16:46,578,591...46,621,379
G
SIN3B
SIN3 transcription regulator family member B
decreases expression
EXP
kojic acid results in decreased expression of SIN3B mRNA
CTD
PMID:16595896
NCBI chr19:16,829,398...16,880,349
Ensembl chr19:16,829,398...16,880,353
G
SLC17A2
solute carrier family 17 member 2
decreases expression
EXP
kojic acid results in decreased expression of SLC17A2 mRNA
CTD
PMID:16595896
NCBI chr 6:25,912,754...25,930,691
Ensembl chr 6:25,912,754...25,930,691
G
SLC25A2
solute carrier family 25 member 2
decreases expression
EXP
kojic acid results in decreased expression of SLC25A2 mRNA
CTD
PMID:16595896
NCBI chr 5:141,302,635...141,304,049
Ensembl chr 5:141,302,635...141,304,049
G
SLC35G5
solute carrier family 35 member G5
decreases expression
EXP
kojic acid results in decreased expression of SLC35G5 mRNA
CTD
PMID:16595896
NCBI chr 8:11,331,012...11,332,360
Ensembl chr 8:11,331,012...11,332,360
G
SLC38A4
solute carrier family 38 member 4
decreases expression
EXP
kojic acid results in decreased expression of SLC38A4 mRNA
CTD
PMID:16595896
NCBI chr12:46,764,761...46,832,431
Ensembl chr12:46,764,761...46,832,408
G
SMC6
structural maintenance of chromosomes 6
decreases expression
EXP
kojic acid results in decreased expression of SMC6 mRNA
CTD
PMID:16595896
NCBI chr 2:17,663,812...17,753,810
Ensembl chr 2:17,663,812...17,800,242
G
SMIM8
small integral membrane protein 8
decreases expression
EXP
kojic acid results in decreased expression of SMIM8 mRNA
CTD
PMID:16595896
NCBI chr 6:87,322,588...87,342,329
Ensembl chr 6:87,322,583...87,399,749
G
SNX10
sorting nexin 10
decreases expression
EXP
kojic acid results in decreased expression of SNX10 mRNA
CTD
PMID:16595896
NCBI chr 7:26,291,862...26,374,383
Ensembl chr 7:26,291,862...26,374,383
G
SOAT2
sterol O-acyltransferase 2
increases expression
EXP
kojic acid results in increased expression of SOAT2 mRNA
CTD
PMID:16595896
NCBI chr12:53,103,486...53,124,535
Ensembl chr12:53,103,486...53,124,535
G
SOD1
superoxide dismutase 1
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of SOD1 mRNA
CTD
PMID:18544905
NCBI chr21:31,659,693...31,668,931
Ensembl chr21:31,659,666...31,668,931
G
SOD2
superoxide dismutase 2
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of SOD2 mRNA
CTD
PMID:18544905
NCBI chr 6:159,669,069...159,762,281
Ensembl chr 6:159,669,069...159,762,529
G
SPATA25
spermatogenesis associated 25
decreases expression
EXP
kojic acid results in decreased expression of SPATA25 mRNA
CTD
PMID:16595896
NCBI chr20:45,886,491...45,891,016
Ensembl chr20:45,886,491...45,887,622
G
SPDYE1
speedy/RINGO cell cycle regulator family member E1
increases expression
EXP
kojic acid results in increased expression of SPDYE1 mRNA
CTD
PMID:16595896
NCBI chr 7:43,997,897...44,010,124
Ensembl chr 7:43,997,897...44,010,124
G
SPP1
secreted phosphoprotein 1
increases expression
EXP
kojic acid results in increased expression of SPP1 mRNA
CTD
PMID:16595896
NCBI chr 4:87,975,714...87,983,411
Ensembl chr 4:87,975,667...87,983,532
G
SPTLC1
serine palmitoyltransferase long chain base subunit 1
increases expression
EXP
kojic acid results in increased expression of SPTLC1 mRNA
CTD
PMID:16595896
NCBI chr 9:92,031,147...92,115,413
Ensembl chr 9:92,000,087...92,115,413
G
SRSF2
serine and arginine rich splicing factor 2
increases expression
EXP
kojic acid results in increased expression of SRSF2 mRNA
CTD
PMID:16595896
NCBI chr17:76,734,115...76,737,411
Ensembl chr17:76,734,115...76,737,333
G
SSX1
SSX family member 1
increases expression
EXP
kojic acid results in increased expression of SSX1 mRNA
CTD
PMID:16595896
NCBI chr X:48,255,392...48,267,444
Ensembl chr X:48,255,392...48,267,444
G
ST13
ST13 Hsp70 interacting protein
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of ST13 mRNA
CTD
PMID:18544905
NCBI chr22:40,824,535...40,856,639
Ensembl chr22:40,824,535...40,856,639
G
ST18
ST18 C2H2C-type zinc finger transcription factor
decreases expression
EXP
kojic acid results in decreased expression of ST18 mRNA
CTD
PMID:16595896
NCBI chr 8:52,110,838...52,409,879
Ensembl chr 8:52,110,838...52,460,959
G
STARD8
StAR related lipid transfer domain containing 8
decreases expression
EXP
kojic acid results in decreased expression of STARD8 mRNA
CTD
PMID:16595896
NCBI chr X:68,647,666...68,725,836
Ensembl chr X:68,647,666...68,725,842
G
STX6
syntaxin 6
increases expression
EXP
kojic acid results in increased expression of STX6 mRNA
CTD
PMID:16595896
NCBI chr 1:180,972,725...181,022,870
Ensembl chr 1:180,972,712...181,023,121
G
SULT1A1
sulfotransferase family 1A member 1
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of SULT1A1 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of SULT1A1 mRNA
CTD
PMID:18544905
NCBI chr16:28,605,258...28,623,375
Ensembl chr16:28,605,196...28,610,044
G
SULT1B1
sulfotransferase family 1B member 1
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of SULT1B1 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of SULT1B1 mRNA
CTD
PMID:18544905
NCBI chr 4:69,721,167...69,760,620
Ensembl chr 4:69,721,167...69,787,961
G
SULT1C2
sulfotransferase family 1C member 2
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of SULT1C2 mRNA
CTD
PMID:18544905
NCBI chr 2:108,288,895...108,309,915
Ensembl chr 2:108,288,639...108,309,915
G
SULT1C3
sulfotransferase family 1C member 3
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of SULT1C1 mRNA
CTD
PMID:18544905
NCBI chr 2:108,239,968...108,265,351
Ensembl chr 2:108,239,968...108,265,351
G
SULT1E1
sulfotransferase family 1E member 1
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid] results in decreased expression of SULT1E1 mRNA [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of SULT1E1 mRNA
CTD
PMID:17917374 PMID:18544905
NCBI chr 4:69,821,122...69,860,145
Ensembl chr 4:69,841,212...69,860,145
G
SULT4A1
sulfotransferase family 4A member 1
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of SULT4A1 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in decreased expression of SULT4A1 mRNA
CTD
PMID:18544905
NCBI chr22:43,824,509...43,862,513
Ensembl chr22:43,824,509...43,862,513
G
SUZ12
SUZ12 polycomb repressive complex 2 subunit
decreases expression
EXP
kojic acid results in decreased expression of SUZ12 mRNA
CTD
PMID:16595896
NCBI chr17:31,937,007...32,001,038
Ensembl chr17:31,937,007...32,001,038
G
SWAP70
switching B cell complex subunit SWAP70
increases expression
EXP
kojic acid results in increased expression of SWAP70 mRNA
CTD
PMID:16595896
NCBI chr11:9,664,077...9,752,993
Ensembl chr11:9,664,077...9,752,993
G
SYF2
SYF2 pre-mRNA splicing factor
decreases expression
EXP
kojic acid results in decreased expression of SYF2 mRNA
CTD
PMID:16595896
NCBI chr 1:25,222,276...25,232,502
Ensembl chr 1:25,222,276...25,232,502
G
SYMPK
symplekin scaffold protein
decreases expression
EXP
kojic acid results in decreased expression of SYMPK mRNA
CTD
PMID:16595896
NCBI chr19:45,815,410...45,863,147
Ensembl chr19:45,815,410...45,863,194
G
SYNCRIP
synaptotagmin binding cytoplasmic RNA interacting protein
increases expression
EXP
kojic acid results in increased expression of SYNCRIP mRNA
CTD
PMID:16595896
NCBI chr 6:85,607,784...85,643,870
Ensembl chr 6:85,607,779...85,644,063
G
TAF15
TATA-box binding protein associated factor 15
decreases expression
EXP
kojic acid results in decreased expression of TAF15 mRNA
CTD
PMID:16595896
NCBI chr17:35,809,484...35,847,242
Ensembl chr17:35,809,482...35,864,615
G
TAL1
TAL bHLH transcription factor 1, erythroid differentiation factor
decreases expression
EXP
kojic acid results in decreased expression of TAL1 mRNA
CTD
PMID:16595896
NCBI chr 1:47,216,290...47,232,335
Ensembl chr 1:47,216,290...47,232,225
G
TBXAS1
thromboxane A synthase 1
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid] results in decreased expression of TBXAS1 mRNA
CTD
PMID:18544905
NCBI chr 7:139,778,242...140,020,293
Ensembl chr 7:139,777,051...140,020,325
G
TCF21
transcription factor 21
decreases expression
EXP
kojic acid results in decreased expression of TCF21 mRNA
CTD
PMID:16595896
NCBI chr 6:133,889,113...133,895,537
Ensembl chr 6:133,889,113...133,895,553
G
TCN1
transcobalamin 1
decreases expression
EXP
kojic acid results in decreased expression of TCN1 mRNA
CTD
PMID:16595896
NCBI chr11:59,852,808...59,866,487
Ensembl chr11:59,852,800...59,866,489
G
TENT4B
terminal nucleotidyltransferase 4B
decreases expression
EXP
kojic acid results in decreased expression of TENT4B mRNA
CTD
PMID:16595896
NCBI chr16:50,152,911...50,235,310
Ensembl chr16:50,152,911...50,235,310
G
TGFB1
transforming growth factor beta 1
multiple interactions
ISO
[Ascorbic Acid co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of TGFB1 mRNA
CTD
PMID:18544905
NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
G
THRB
thyroid hormone receptor beta
decreases expression
EXP
kojic acid results in decreased expression of THRB mRNA
CTD
PMID:16595896
NCBI chr 3:24,117,153...24,495,708
Ensembl chr 3:24,117,153...24,495,756
G
TIE1
tyrosine kinase with immunoglobulin like and EGF like domains 1
decreases expression
EXP
kojic acid results in decreased expression of TIE mRNA
CTD
PMID:16595896
NCBI chr 1:43,300,982...43,323,108
Ensembl chr 1:43,300,982...43,323,108
G
TIRAP
TIR domain containing adaptor protein
decreases expression
EXP
kojic acid results in decreased expression of TIRAP mRNA
CTD
PMID:16595896
NCBI chr11:126,283,093...126,294,933
Ensembl chr11:126,282,497...126,298,845
G
TMCO5A
transmembrane and coiled-coil domains 5A
increases expression
EXP
kojic acid results in increased expression of TMCO5 mRNA
CTD
PMID:16595896
NCBI chr15:37,934,640...38,040,865
Ensembl chr15:37,921,939...37,967,724
G
TMEM217
transmembrane protein 217
increases expression
EXP
kojic acid results in increased expression of TMEM217 mRNA
CTD
PMID:16595896
NCBI chr 6:37,212,181...37,258,144
Ensembl chr 6:37,212,180...37,258,155
G
TMEM59L
transmembrane protein 59 like
decreases expression
EXP
kojic acid results in decreased expression of TMEM59L mRNA
CTD
PMID:16595896
NCBI chr19:18,612,870...18,621,039
Ensembl chr19:18,607,430...18,621,039
G
TMX1
thioredoxin related transmembrane protein 1
decreases expression
EXP
kojic acid results in decreased expression of TMX1 mRNA
CTD
PMID:16595896
NCBI chr14:51,240,247...51,257,655
Ensembl chr14:51,240,162...51,257,655
G
TNF
tumor necrosis factor
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of TNF mRNA
CTD
PMID:18544905
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
TNFAIP8L1
TNF alpha induced protein 8 like 1
decreases expression
EXP
kojic acid results in decreased expression of TNFAIP8L1 mRNA
CTD
PMID:16595896
NCBI chr19:4,639,516...4,655,568
Ensembl chr19:4,639,516...4,655,568
G
TNFSF10
TNF superfamily member 10
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of TNFSF10 mRNA
CTD
PMID:18544905
NCBI chr 3:172,505,508...172,523,430
Ensembl chr 3:172,505,508...172,523,475
G
TOR4A
torsin family 4 member A
decreases expression
EXP
kojic acid results in decreased expression of TOR4A mRNA
CTD
PMID:16595896
NCBI chr 9:137,277,726...137,282,641
Ensembl chr 9:137,277,726...137,282,641
G
TP53
tumor protein p53
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of TP53 mRNA [Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of TRP53 mRNA
CTD
PMID:17917374 PMID:18544905
NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,538
G
TP53BP2
tumor protein p53 binding protein 2
increases expression
EXP
kojic acid results in increased expression of TP53BP2 mRNA
CTD
PMID:16595896
NCBI chr 1:223,779,893...223,845,947
Ensembl chr 1:223,779,893...223,845,954
G
TPCN1
two pore segment channel 1
increases expression
EXP
kojic acid results in increased expression of TPCN1 mRNA
CTD
PMID:16595896
NCBI chr12:113,221,464...113,298,585
Ensembl chr12:113,221,050...113,298,585
G
TPST2
tyrosylprotein sulfotransferase 2
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid] results in decreased expression of TPST2 mRNA
CTD
PMID:17917374
NCBI chr22:26,521,996...26,590,132
Ensembl chr22:26,521,996...26,596,717
G
TRADD
TNFRSF1A associated via death domain
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of TRADD mRNA; [Diethylnitrosamine co-treated with kojic acid] results in decreased expression of TRADD mRNA
CTD
PMID:18544905
NCBI chr16:67,154,185...67,159,909
Ensembl chr16:67,154,185...67,159,909
G
TRAM1
translocation associated membrane protein 1
decreases expression
EXP
kojic acid results in decreased expression of TRAM1 mRNA
CTD
PMID:16595896
NCBI chr 8:70,573,218...70,608,416
Ensembl chr 8:70,573,218...70,608,416
G
TRAM2
translocation associated membrane protein 2
decreases expression
EXP
kojic acid results in decreased expression of TRAM2 mRNA
CTD
PMID:16595896
NCBI chr 6:52,497,408...52,577,060
Ensembl chr 6:52,497,408...52,577,060
G
TREM1
triggering receptor expressed on myeloid cells 1
decreases expression
EXP
kojic acid results in decreased expression of TREM1 mRNA
CTD
PMID:16595896
NCBI chr 6:41,267,385...41,286,682
Ensembl chr 6:41,267,926...41,286,682
G
TRMT10C
tRNA methyltransferase 10C, mitochondrial RNase P subunit
decreases expression
EXP
kojic acid results in decreased expression of TRMT10C mRNA
CTD
PMID:16595896
NCBI chr 3:101,561,868...101,566,446
Ensembl chr 3:101,561,868...101,566,446
G
TSPAN8
tetraspanin 8
increases expression
EXP
kojic acid results in increased expression of TSPAN8 mRNA
CTD
PMID:16595896
NCBI chr12:71,125,096...71,157,999
Ensembl chr12:71,125,085...71,441,898
G
TTC9
tetratricopeptide repeat domain 9
increases expression
EXP
kojic acid results in increased expression of TTC9 mRNA
CTD
PMID:16595896
NCBI chr14:70,641,916...70,675,366
Ensembl chr14:70,641,916...70,675,366
G
TTK
TTK protein kinase
decreases expression
EXP
kojic acid results in decreased expression of TTK mRNA
CTD
PMID:16595896
NCBI chr 6:80,004,649...80,042,527
Ensembl chr 6:80,003,887...80,042,527
G
TULP3
TUB like protein 3
decreases expression
EXP
kojic acid results in decreased expression of TULP3 mRNA
CTD
PMID:16595896
NCBI chr12:2,890,891...2,941,138
Ensembl chr12:2,877,223...2,941,138
G
TWF1
twinfilin actin binding protein 1
decreases expression
EXP
kojic acid results in decreased expression of TWF1 mRNA
CTD
PMID:16595896
NCBI chr12:43,793,723...43,806,317
Ensembl chr12:43,793,723...43,806,328
G
TYR
tyrosinase
decreases activity increases expression
ISO EXP
kojic acid results in decreased activity of TYR protein kojic acid results in increased expression of TYR mRNA; kojic acid results in increased expression of TYR protein
CTD
PMID:23738040 PMID:27586645
NCBI chr11:89,177,875...89,295,759
Ensembl chr11:89,177,875...89,295,759
G
TYRP1
tyrosinase related protein 1
decreases expression
ISO
kojic acid results in decreased expression of TYRP1 protein
CTD
PMID:27586645
NCBI chr 9:12,693,385...12,710,285
Ensembl chr 9:12,685,439...12,710,285
G
UBE2D4
ubiquitin conjugating enzyme E2 D4 (putative)
decreases expression
EXP
kojic acid results in decreased expression of UBE2D4 mRNA
CTD
PMID:16595896
NCBI chr 7:43,926,436...43,956,136
Ensembl chr 7:43,926,436...43,956,136
G
UBE2E1
ubiquitin conjugating enzyme E2 E1
decreases expression
EXP
kojic acid results in decreased expression of UBE2E1 mRNA
CTD
PMID:16595896
NCBI chr 3:23,805,955...23,891,640
Ensembl chr 3:23,805,955...23,891,640
G
UBE2M
ubiquitin conjugating enzyme E2 M
decreases expression
EXP
kojic acid results in decreased expression of UBE2M mRNA
CTD
PMID:16595896
NCBI chr19:58,555,712...58,558,611
Ensembl chr19:58,555,712...58,558,954
G
UBR7
ubiquitin protein ligase E3 component n-recognin 7
increases expression
EXP
kojic acid results in increased expression of UBR7 mRNA
CTD
PMID:16595896
NCBI chr14:93,207,256...93,229,215
Ensembl chr14:93,207,241...93,229,215
G
UFD1
ubiquitin recognition factor in ER associated degradation 1
increases expression
EXP
kojic acid results in increased expression of UFD1 mRNA
CTD
PMID:16595896
NCBI chr22:19,449,911...19,479,193
Ensembl chr22:19,449,911...19,479,202
G
UGT1A3
UDP glucuronosyltransferase family 1 member A3
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of UGT1A2 mRNA
CTD
PMID:17917374
NCBI chr 2:233,729,042...233,773,300
Ensembl chr 2:233,729,042...233,773,300
G
UGT1A6
UDP glucuronosyltransferase family 1 member A6
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of UGT1A6 mRNA
CTD
PMID:18544905
NCBI chr 2:233,691,702...233,773,300
Ensembl chr 2:233,691,607...233,773,300
G
UNC5C
unc-5 netrin receptor C
decreases expression
EXP
kojic acid results in decreased expression of UNC5C mRNA
CTD
PMID:16595896
NCBI chr 4:95,162,504...95,548,973
Ensembl chr 4:95,162,504...95,549,206
G
UNG
uracil DNA glycosylase
multiple interactions
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of UNG mRNA
CTD
PMID:17917374
NCBI chr12:109,097,597...109,110,992
Ensembl chr12:109,097,597...109,126,725
G
USP1
ubiquitin specific peptidase 1
decreases expression
EXP
kojic acid results in decreased expression of USP1 mRNA
CTD
PMID:16595896
NCBI chr 1:62,436,395...62,451,804
Ensembl chr 1:62,436,297...62,451,804
G
USP44
ubiquitin specific peptidase 44
decreases expression
EXP
kojic acid results in decreased expression of USP44 mRNA
CTD
PMID:16595896
NCBI chr12:95,516,560...95,551,681
Ensembl chr12:95,516,560...95,551,476
G
UTP11
UTP11 small subunit processome component
increases expression
EXP
kojic acid results in increased expression of UTP11 mRNA
CTD
PMID:16595896
NCBI chr 1:38,012,734...38,024,820
Ensembl chr 1:38,009,258...38,024,820
G
WNT10A
Wnt family member 10A
decreases expression
EXP
kojic acid results in decreased expression of WNT10A mRNA
CTD
PMID:16595896
NCBI chr 2:218,874,116...218,893,928
Ensembl chr 2:218,880,852...218,899,581
G
YEATS2
YEATS domain containing 2
increases expression
EXP
kojic acid results in increased expression of YEATS2 mRNA
CTD
PMID:16595896
NCBI chr 3:183,697,797...183,812,624
Ensembl chr 3:183,697,797...183,812,624
G
ZC3H15
zinc finger CCCH-type containing 15
decreases expression
EXP
kojic acid results in decreased expression of ZC3H15 mRNA
CTD
PMID:16595896
NCBI chr 2:186,486,260...186,509,361
Ensembl chr 2:186,486,253...186,509,361
G
ZDHHC20
zinc finger DHHC-type palmitoyltransferase 20
decreases expression
EXP
kojic acid results in decreased expression of ZDHHC20 mRNA
CTD
PMID:16595896
NCBI chr13:21,372,571...21,459,303
Ensembl chr13:21,348,784...21,459,370
G
ZFAND1
zinc finger AN1-type containing 1
decreases expression
EXP
kojic acid results in decreased expression of ZFAND1 mRNA
CTD
PMID:16595896
NCBI chr 8:81,701,331...81,721,304
Ensembl chr 8:81,701,334...81,732,903
G
ZKSCAN8
zinc finger with KRAB and SCAN domains 8
decreases expression
EXP
kojic acid results in decreased expression of ZKSCAN8 mRNA
CTD
PMID:16595896
NCBI chr 6:28,141,635...28,159,460
Ensembl chr 6:28,141,883...28,159,460
G
ZMYND15
zinc finger MYND-type containing 15
decreases expression
EXP
kojic acid results in decreased expression of ZMYND15 mRNA
CTD
PMID:16595896
NCBI chr17:4,739,833...4,746,119
Ensembl chr17:4,739,833...4,746,119
G
ZNF146
zinc finger protein 146
decreases expression
EXP
kojic acid results in decreased expression of ZNF146 mRNA
CTD
PMID:16595896
NCBI chr19:36,214,723...36,238,768
Ensembl chr19:36,214,602...36,238,771
G
ZNF414
zinc finger protein 414
decreases expression
EXP
kojic acid results in decreased expression of ZNF414 mRNA
CTD
PMID:16595896
NCBI chr19:8,509,678...8,514,167
Ensembl chr19:8,509,678...8,514,167
G
ZNF438
zinc finger protein 438
increases expression
EXP
kojic acid results in increased expression of ZNF438 mRNA
CTD
PMID:16595896
NCBI chr10:30,844,632...31,032,411
Ensembl chr10:30,820,207...31,031,937
G
ZNF483
zinc finger protein 483
decreases expression
EXP
kojic acid results in decreased expression of ZNF483 mRNA
CTD
PMID:16595896
NCBI chr 9:111,525,179...111,578,136
Ensembl chr 9:111,525,159...111,577,844
G
ZNF497
zinc finger protein 497
decreases expression
EXP
kojic acid results in decreased expression of ZNF497 mRNA
CTD
PMID:16595896
NCBI chr19:58,354,357...58,362,751
Ensembl chr19:58,354,357...58,362,848
G
ZP2
zona pellucida glycoprotein 2
decreases expression
EXP
kojic acid results in decreased expression of ZP2 mRNA
CTD
PMID:16595896
NCBI chr16:21,197,450...21,214,510
Ensembl chr16:21,197,450...21,214,510
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all